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Although in silico database search methods remain more popular for shotgun 
proteomics methods, de novo sequencing offers the ability to identify proteins lacking 
sequenced genomes and ones with subtle splice variants or truncations.  Ultraviolet 
photodissociation (UVPD) of peptides derivatized by selective attachment of a 
chromophore at the N-terminus generated characteristic series of y ions. The UVPD 
spectra of the chromophore-labelled peptides were simplified and thus amenable to de 
novo sequencing.  
 E.coli lysates were modified by the use of carbamylation and the attachment of a 
UV chromophore to the N-terminus of digested peptides. UVPD of the resulting peptides 
generated clean sets of y ions. A novel de novo algorithm, UVnovo, afforded high 
confidence identification of thousands of peptides from an E. coli lysate and allowed 
UVPD/CID paired spectra to be searched. E.coli lysate peptides were analyzed in 
alternating scans by UVPD and CID on the same precursors to generate paired 
 vii 
UVPD/CID spectra. UVnovo enabled sequence tag de novo sequencing of peptides in 
order to find matching sequences from a database. Ultimately the UVnovo functioned as 
a standalone de novo sequencing program or a hybrid de novo/database search program. 
In an effort to better characterize the fragmentation pathways promoted by 
ultraviolet photoexcitation in comparison to CID, six adrenocorticotropic hormone 
(ACTH) peptides in a range of charge states were subjected to 266 nm ultraviolet 
photodissociation (UVPD), 193 nm UVPD, and CID.  While both UVPD and CID led to 
preferential cleavage of the Y-S bond for all ACTH peptides (except ACTH (1-39)), 
UVPD was far less dependent on charge state and location of basic sites for the 
production of C-terminal and N-terminal ions. 
 viii 
Table of Contents 
Chapter 1Introduction ..............................................................................................1 
1.1 Introduction ...............................................................................................1 
1.2 Tandem Mass Spectrometry for Bottom-Up Proteomics ..........................1 
1.2.1 Protein/Peptide Product Ion Nomenclature ..................................5 
1.2.2 Collision-Induced Dissociation (CID) ..........................................6 
1.2.3  Electron Capture/Transfer Dissociation (ECD/ETD), Surface 
Induced Dissociation (SID) and Infrared Multiphoton Dissociation 
(IRMPD) .......................................................................................8 
1.2.4 Ultraviolet photodissociation (UVPD) .........................................9 
1.3 Derivatization of Proteins/Peptides.........................................................13 
1.3.1 Derivatization for De Novo Sequencing .....................................14 
1.4 Chapter Overview: ..................................................................................16 
1.5 References ...............................................................................................18 
Chapter 2 Experimental .........................................................................................32 
2.1 Mass Spectrometry..................................................................................32 
2.2 Liquid Chromatography ..........................................................................33 
2.3 Chemicals ................................................................................................34 
2.4 Preparation of AMCA Modified Samples ..............................................35 
2.4.1 Peptide Samples ..........................................................................35 
2.4.1 Proteins: Guanidination ..............................................................35 
2.4.2 Proteins: Carbamylation..............................................................36 
2.5 Ultraviolet Photodissociation ..................................................................37 
2.5.1 UVPD at 193 nm .........................................................................37 
2.5.2 UVPD at 266 nm .........................................................................37 
2.5.3 UVPD at 351 nm .........................................................................37 
2.6 Automated Database Searching ..............................................................38 
2.6.1 SEQUEST ...................................................................................38 
2.6.2 PEAKS ........................................................................................39 
 ix 
2.7 References ...............................................................................................40 
Chapter 3 De Novo Sequencing of Peptides Using Selective 351 nm Ultraviolet 
Photodissociation Mass Spectrometry ..........................................................41 
3.1 Overview .................................................................................................41 
3.2 Introduction .............................................................................................41 
3.3 Experimental ...........................................................................................47 
3.3.1 Materials .....................................................................................47 
3.3.2 Preparation of Mutant Green Fluorescent Proteins .....................47 
3.3.4 Modification of Peptides and Proteins ........................................48 
3.3.5 MS analysis of Modified Peptides ..............................................49 
3.3.6 LCMS/MS analysis of Modified Proteins...................................50 
3.3.7 PEAKS analysis ..........................................................................50 
3.3.8 SEQUEST analysis .....................................................................51 
3.4 Results .....................................................................................................51 
3.4.1 351 nm UVPD of Modified Peptides ..........................................51 
3.4.2 De novo Sequencing of Model Proteins .....................................54 
3.4.3 De novo Sequencing of Green Fluorescent Proteins. .................61 
3.5 Conclusions .............................................................................................62 
3.6 References ...............................................................................................64 
Chapter 4 UVnovo: A Novel De Novo Sequencing Algorithm Using Single Series of 
Fragment Ions via Chromophore Tagging and 351 nm UVPD ....................75 
4.1 Overview .................................................................................................75 
4.2 Introduction .............................................................................................75 
4.3 Experimental ...........................................................................................79 
4.3.1 Materials .....................................................................................79 
4.3.2 Modification of E.coli Lysate. ....................................................80 
4.3.3 LC-MS/MS analysis of E.coli lysate ..........................................81 
4.3.4 SEQUEST ...................................................................................82 
4.3.5 De novo analysis using UVnovo .................................................82 
4.3.5.1 Generation of high confidence data sets .........................83 
 x 
4.3.5.2 UVnovo ...........................................................................83 
4.3.5.3 Deconvolution of fragmentation patters .........................84 
4.3.5.4 Scoring of fragment sites ................................................87 
4.3.5.5 Finding the best path .......................................................88 
4.3.5.6 Scoring de novo reconstructions .....................................89 
4.4 Results .....................................................................................................90 
4.4.1 Lysine capping with carbamylation ............................................90 
4.4.2 Validation of UVnovo using E.coli lysate ..................................92 
4.5 Conclusions ...........................................................................................100 
4.6 References .............................................................................................102 
Chapter 5 Incorporation of UVPD/CID paired spectra Analysis and De Novo 
Sequence Tag /Database look-up to Expand the Capabilities of UVnovo .110 
5.1 Overview ...............................................................................................110 
5.2 Introduction ...........................................................................................111 
5.3 Experimental .........................................................................................114 
5.3.1 Materials ...................................................................................114 
5.3.2 Modification E.coli lysate .........................................................115 
5.3.3 LC-MS/MS analysis of E.coli lysate ........................................115 
5.3.4 PEAKS analysis ........................................................................116 
5.3.5 SEQUEST analysis ...................................................................116 
5.3.6 UVnovo Modifications .............................................................117 
5.3.6.1 Merging UVPD/CID paired spectra..............................117 
5.3.6.2 Hybrid sequence tag database search ............................117 
5.4 Results ...................................................................................................118 
5.4.1 UVnovo incorporation of paired spectra ...................................118 
5.4.2 Sequence Tag Analysis .............................................................125 
5.5 Conclusions ...........................................................................................126 
5.6 References .............................................................................................127 
 xi 
Chapter 6 Comparison of Ultraviolet Photodissociation and Collision Induced 
Dissociation of Adrenocorticotropic Hormone Peptides ............................135 
6.1 Overview ...............................................................................................135 
6.2 Introduction ...........................................................................................135 
6.3 Experimental .........................................................................................140 
6.3.1 Materials ...................................................................................140 
6.3.2 Mass Spectrometry....................................................................140 
6.3.3 Analysis of Spectra ...................................................................141 
6.4 Results ...................................................................................................141 
6.4.1 266nm UVPD, 193 nm UPVD, and CID of ACTH peptides ...141 
6.4.2 Fragmentation Trends Observed in ACTH peptides ................148 
6.4.3 Comparison of 266 nm, 193 nm, CID sequence coverage for ACTH 
peptides .....................................................................................164 
6.5 Conclusions ...........................................................................................169 
6.6 References .............................................................................................171 








Advancements in the field of proteomics over the past several decades are due in 
large part to the capabilities of mass spectrometry (MS). Improvement of MS 
instrumentation has allowed investigation of complex cell lysates making it possible to 
identify thousands of proteins as well as enabling more comprehensive characterization 
of proteins such as mapping new post translational modifications and sequence 
mutations. With such endeavors becoming the mainstay of many mass spectrometric-
based proteomics applications, more powerful data analysis algorithms have been 
required in order to support and improve interpretation of MS/MS spectra. Such 
algorithms are typically trained based on large datasets and optimized to evaluate specific 
types of MS/MS fragmentation of peptides in order to achieve the best possible 
confidence. The focus of this dissertation is to develop and optimize tandem MS/MS 
techniques where peptides are derivatized and fragmented using ultraviolet 
photodissociation (UVPD) giving uniquely simplified fragmentation patterns. In order to 
take full advantage of the simplified UVPD mass spectra, a novel data analysis program 
allowing high confidence identification of proteins and peptides was used. 
 
1.2 TANDEM MASS SPECTROMETRY FOR BOTTOM-UP PROTEOMICS 
For mass spectrometry-based proteomics the most widely strategy is termed 
bottom-up analysis. In this approach proteins are enzymatically digested to produce more 
readily analyzed peptides that are representative of the original proteins. The peptides are 
 2 
separated using high performance liquid chromatography and analyzed using MS/MS.1 
Typically algorithms are used to assign fragment ions of each peptide which is then 
matched to a protein. There are two different types of programs typically used perform 
such searches: in silico database search methods and de novo sequencing. 
8
 
In silico database searches take advantage of immense amount of known genomic 
sequence information by using complex algorithms to match experimental MS/MS 
patterns to theoretical tandem mass spectra generated in silico for peptides from large 
databases of known proteins. Since there is no single best way to properly exploit such 
data, various in silico methods have been developed with the more popular ones being 
SEQUEST2, Mascot3, MassMatrix4, OMSSA5, and X!Tandem6. Each of these programs 
provide reliable results while taking different approaches to the processing of MS/MS 
data to yield peptide and protein identifications. SEQUEST, for example, uses a rapid 
survey step to identify all reasonable protein sequence based on the MS/MS spectra of 
peptides, and compares mass to charge ratios for fragments found to the mass to charge 
ratios of fragment ions predicted for amino acid sequences via a cross-correlation 
function.2 Mascot takes into account the intact mass of peptide precursor ions as well as 
MS/MS data for one or more peptides and applies a probability-based scoring algorithm 
that calculates a score based on the statistical significance of matching a peptide fragment 
to fragments calculated from a sequence database.3 MassMatrix also takes advantage of  
probability-based scoring for peptides but uses a unique approach by applying two 
independent scoring models, a descriptive model and a statistical model, where each 
score is useful for validating a peptide match.7 Alternatively,  OMSSA focuses more on 
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improving the rate at which data is analyzed by applying a probability-based algorithm 
and streamlining the analysis.5 X!Tandem is similarly aimed to decrease analysis time by 
using a rapid survey step to identify all protein sequences that are reasonable candidates 
and uses these as models; 8 adapted to an open source system named Global Proteome 
Machine for which protein identification data could be freely stored and used.6 Direct 
comparisons of in silico programs demonstrate that many programs perform at an 
acceptable level with comparable results, thus leading to ongoing use of all of these 
methods .4,9 
The use of mass spectrometry and in silico algorithms to identify thousands of 
proteins in cell lysate have accelerated many advances in the field of cellular 
proteomics.10 Despite the success of this approach, in silico algorithms are limited in that 
only proteins from organisms with sequenced genomes can be identified. Furthermore, in 
silico programs have also been shown to suffer in the identification of sequence 
mutations, truncated proteins, and post-translational modifications (PTM).11 In an effort 
to overcome these deficiencies de novo sequencing algorithms were developed.12–14 De 
novo sequencing methods do not require prior information from a protein database; 
instead tandem MS data is directly interpreted based on the individual masses of the 
peptides and fragment ions and the mass differences of the fragment ions. By not 
requiring a fully sequenced genome in order to identify peptides, de novo sequencing 
allows greater flexibility in identifying unexpected mutations or PTMs. Similar to 
database search algorithms, the complexity required for effective de novo algorithms has 
resulted in various alternative approaches aiming toward the same goal. The most 
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common and widely used programs today are PEAKS15, PepNovo16, NovoHMM17, 
MSnovo18, and Vonode19. Each of these programs utilizes a different approach for scoring 
the MS/MS spectra, and some of the key scoring metrics are based on predicting the 
number of amino acids based on observed precursor mass. Scoring metrics are also based 
on the algorithm making assessments of fragments to determine which peak is selected as 
the next loss of a amino acid to give a logical path through a MS/MS spectra to construct 
a peptide sequence that is best fit for the observed fragment ions. PEAKS uses a four step 
process which involves preprocessing (noise filtering, peak centering and deconvolution), 
candidate computation, refined scoring, and global and positional confidence scoring.15 
PepNovo focuses on the chemical and physical rules of peptide fragmentation to generate 
a scoring program.16 NovoHMM uses a generative hidden Markov model in order to 
better distinguish between signal and noise peaks.17 MSnovo uses a probabilistic scoring 
function with a mass array-based dynamic programming algorithm.18 The most recent 
addition to the list of de novo programs is Vonode which uses a unique tag scoring and 
novel spectral graph to generate de novo scoring results.19 Regardless of which algorithm 
is used, the success of de novo sequencing hinges on the quality of the MS/MS spectra 
collected. An overabundance of fragment ions from redundant backbone cleavages or 
neutral losses will inevitably lead to a spectrum that is difficult to interpret. Too few 
fragment ions (a result of missed cleavages along the backbone of the peptide), however, 
will result in derivation of only partial sequence information. 
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1.2.1 Protein/Peptide Product Ion Nomenclature 
Dissociation of protein/peptides ions promoted by a given activation method will 
result in predictable fragmentation often observed as cleavage along the peptide 
backbone. It is this predictability of peptide fragmentation that allows algorithms to be 
utilized for searching MS/MS data. A standardized nomenclature has been established for 
peptide fragmentation which has been accepted throughout the mass spectrometry 
community.20 An example of this nomenclature is illustrated in Figure 1.1 where a letter 
of a,b, or c denotes a product ion which contains the N-terminus of the peptide and x, y, 
or z indicates an ion which contains the C-terminus. The formation of a/x ions is the  N- 
and C-terminus fragments which are formed by the cleavage of the Cα –C bond, whereas 
the b/y ions result from the cleavage of a N-C amide bond and c/z ions are due to the 
cleavage of a N-Cα bond. A numeric subscript associated with a fragment indicates how 
many amino acids are found between the cleavage site and the respective terminus. Each 
pair of fragments is typically associated with certain types of activation methods. 
 
Figure 1.1: Protein/Peptide Fragmentation Nomenclature 
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For example b- and y- type ions, which arise from cleavage of the most labile backbone 
bond (the N-C amide bond) of peptides, are generally the most common and abundant 
ions formed by thermal activation methods (vibrational excitation). These fragments ions 
are typically produced by collision induced dissociation (CID) or some photodissociation 
(PD)21 methods which have lower energy photons. CID, in particular, is a step-wise 
vibrational activation process.  Peptides undergo radical driven fragmentation upon 
electron capture dissociation (ECD)22 or electron transfer dissociation (ETD),23 which 
cause cleavage of the N-Cα bond and gives c- and z-type ions. The a- and x-type ions are 
typically only produced from higher energy activation methods such as ultraviolet 
photodissociation (UVPD)21 which results in the cleavage of the Cα –C bond of the 
peptide backbone. 
. 
1.2.2 Collision-Induced Dissociation (CID) 
CID is the most common form of ion activation used today. Ions are fragmented 
in CID by first isolating a precursor ion and then using a voltage to accelerate the isolated 
precursor ions into a neutral gas molecules.  These collision events cause conversion of 
the kinetic energy of the ion into internal energy.  The amount of energy converted per 
collision is small, therefore typically several collisions are required in order for a 
molecule to accumulate enough internal energy for dissociation to occur. CID is currently 
used in almost every type of mass spectrometer, including quadrupole ion traps (IT), 
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Fourier transform ion cyclotron resonance (FTICR) ion traps, hybrid orbitraps, tandem 
quadrupole instruments, and time-of-flight (TOF) mass spectrometers. 
  In the field of proteomics, the collisional heating results in characteristic 
backbone cleavage yielding b- and y- type ions and is the most common method for 
sequencing peptides and identifying PTMs.24 Over the years CID has been shown to be an 
effective and robust method for identifying peptides from complex protein mixtures, so it 
is no surprise that it is often considered the “gold standard” method of fragmentation. 25 
Despite all of the success seen with CID, there are still limitations to its use. Certain 
amino acids side-chains increase the lability of peptide backbone bonds and with the 
vibrational excitation of CID preferential cleavage is often observed at these sites (e.g. 
proline, histidine, glutamic acid, and aspartic acid). In additional to preferential 
cleavages, uninformative neutral losses such as water or ammonia are common. In 
addition, labile post-translational modifications may be cleaved, thus preventing site 
localization of the modifications.  Ion traps suffer from an additional disadvantage for 
CID.  As a result of the adjustment of the radiofrequency voltage trapping voltage during 
ion activation to ensure adequate ion energization, the lower m/z range is truncated.26 
This problem is known as the low mass cutoff (LMCO) and can be detrimental to 
database search methods looking for low mass PTMs or short N-terminal and C-terminal 
fragment ions.27 This limitation has been alleviated by the recent development of higher 
energy collisional activation dissociation (HCD) in ion traps.
28 
HCD is performed by 
accelerating the ions through a separate collision cell rather than storing them in an ion 
trap. Fragment ions formed in the HCD cell are then transferred out of the cell for 
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analysis. By preforming ion activation in this collision cell rather than in the ion trap, 
HCD is independent of the rf trapping voltage which alleviates the LMCO issues found in 
CID as well giving higher energy deposition which yields more informative MS/MS 
spectra. 
The general shortcomings of CID have led to the development of alternative 
activation techniques, such as electron-based methods
22,23





 While it is unlikely that any new method will ever 
completely replace CID for bottom-up protein analysis due to its well-established usage, 
other dissociation methods allow a more complete analysis of proteins and are often used 
in a complementary manner in conjunction with CID. 
1.2.3  Electron Capture/Transfer Dissociation (ECD/ETD), Surface Induced 
Dissociation (SID) and Infrared Multiphoton Dissociation (IRMPD) 
Various alternative activation methods have been developed, each offering 
particular advantages and unique applications. For example SID uses a surface as a target 
instead of an inert gas.  The motivation behind using a surface is  thatgreater energy 
transfer from a single collision with a massive target (the surface).
29
 Using SID for 
peptide fragmentation results in traditional CID-like ion (b- and y- fragments) and gives 
comparable sequence coverage to that observed with CID.
30
 SID however has also been 
shown to be an extremely effective tool for probing mechanisms of peptide 





In a rather different approach ECD and ETD are electron-based dissociation 
methods resulting in cleavage of the N-Cα bond along the peptide backbone yielding c- 
and z- type ions. This fragmentation is the result of exothermic reactions between a 
charged cation and either low-energy electrons (ECD) or radical anions (ETD). These 
dissociation techniques are radical mediated and have been shown to be effective for 
characterizing post-translational modifications
23,32–34




Finally IRMPD is commonly implemented with a CO2 laser that emits photons at 
10.6 µm. Fragmentation with IRMPD yields in b- and y- type ions as a result of the 
peptide absorbing photons  via heating of various vibrational modes from C-N, C-C, and 
C-O bonds. IRMPD is typically performed with a continuous laser during activation 
which allows secondary dissociation to occur and yielding more diagnostic fragment ions 
compared to CID.
36
 IRMPD also boasts the advantage of having a wider m/z trapping 
range than CID as rf trapping voltages can be lowered during activation.
37
   
1.2.4 Ultraviolet photodissociation (UVPD) 
UVPD is an alternative activation method that uses a laser at an ultraviolet 
wavelength in order to excite peptides based on absorption of high energy photons (from 
3.5 eV up to 7.9 eV). While other photodissociation methods using infrared or visible 
photons have been proven to be effective over the last few years, UVPD has established 
itself as an extremely powerful technique for analyzing proteins and peptides.21 The 
wavelengths used for UVPD have generally been ones readily available from pulsed 
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excimer or YAG lasers, each taking advantage of a unique chromophore of the peptide or 
protein for photoabsorption. 
157 nm and 193 nm UVPD are unique in that these photons are absorbed by 
amide bonds, meaning that the entire peptide backbone acts as a chromophore, in 
addition to aromatic amino acid side chains. Each photon carries a large amount of 
energy (7.9 and 6.4 eV, respectively), exciting proteins and peptides into higher 
electronic states. This allows access to diverse fragmentation pathways, including ones 
with higher activation energies. The resulting product ions from this type of UVPD are 
often spread across all six fragment (a,b,c,x,y, and z) types discussed in section 1.2.1. of 
the Introduction. First reports of such fragmentation date back to the 1980’s,38–40 however, 
it was not until the past decade that the method started to become more widespread. 
UVPD using a 157 nm excimer laser has been integrated with both an ion trap mass 
spectrometer as well as a TOF platform, yielding a diverse set of fragments proving to be 
useful for de novo sequencing of peptides. 41–44 Similarly, 193 nm UVPD has been used 
for dissociation of  peptides in a wide array of bottom-up workflows.45–49 Recently, 193 
nm UVPD was applied to analysis of intact proteins, showing that the extensive 
fragmentation affords complete characterization of proteins.50 This new application of 
193 nm has already demonstrated to be an extremely useful tool for protein analysis51–56, 
however it is still early in its use so it is unlikely that its full potential has been reached. 
While delivering slightly less energy per photon (4.7 eV), 266 nm UVPD is 
similar to 157 nm and 193 nm in that a, b, c, x, y, and z are observed from peptide 
fragmentation. The major difference for 266 nm UVPD is that this wavelength is not 
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absorbed by the peptide backbone and is instead primarily absorbed by the aromatic side-
chains of tryptophan, phenylalanine, and tyrosine residues.57,58 Derivatization (discussed 
more in section 1.3 of the Introduction) of peptides with UV chromophores has extended 
the use of 266 nm photons.59 266 nm UVPD is also unique in that peptides or proteins 
containing disulfides bonds exhibit a homolytic cleavage of the disulfide and C-S bonds 
upon irradiation allowing cysteine residues to be mapped.60 In another strategy, iodination 
of tyrosine residues prior to 266 nm UVPD promoted radical directed dissociation which 
has proven useful for probing gas-phase protein structure61–64, for pinpointing 
phosphorylation sites65, and for differentiating between D- and L amino acids in 
peptides.66 Despite the recent applications using 266 nm UVPD, very little attention has 
focused on the pathways and distribution of fragment ions. Chapter 6 will report findings 
on 266 nm UVPD fragmentation as a function of charge state and peptide composition. 
Finally, 351 nm (from a XeF excimer laser) or 355 nm (third harmonic of a 
Nd:YAG laser) UVPD has experienced more selective use in the field of proteomics 
compared to its counterparts. Photons from 351 nm light still deliver a moderate amount 
of energy (3.5 eV); however, unlike 157 nm, 193 nm, or 266 nm UVPD there is no part 
of the peptide which absorbs light around this wavelength, thus chromophores must be 
incorporated. When a peptide containing an appropriate a chromophore is exposed to 351 
nm irradiation, b/y-type fragment ions are observed similar to conventional CID 
activation. The fact that standard peptides do not absorb 350 nm photons means that 
UVPD can be used a highly selective activation method for strategically-tagged peptides. 
For example, 351 nm UVPD has been employed to identify the antigen binding regions 
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of antibodies by using a cysteine selective chromophore.67 Solvent accessibility of 
proteins has been evaluated using 351 nm UVPD  in conjunction with a chromogenic 
chemical probe of lysine side-chains.68 Recently another method has also reported that 
tagging of histidine and tyrosine amino acids via a chromogenic diazotisation reaction 
allowed bottom-up peptide analysis to be streamlined.69 It was also shown that if a UV 
chromophore was attached to the N-terminus of peptides prior to exposure to 355 nm UV 
irradiation,  the resulting MS/MS spectra contained a clean series of solely y-type ions.70 
The elimination of the b-ions was due to the fact that these fragment ions retained the UV 
chromophore , a factor that led to subsequent photon absorption and annihilation of the b 
ions, a process  illustrated in Figure 1.2. This method showed great promise as an 
alternative activation for generating spectra ideal for de novo sequencing, and it is the 





Figure 1.2: Example of 351 nm UVPD fragmentation. The  b ions retain the UV 
chromophore making them susceptible to annihilation upon subsequent UV 
irradiation. 
 
1.3 DERIVATIZATION OF PROTEINS/PEPTIDES 
The use of chemical tags to modify functional groups via derivatization is a 
popular technique used to extend the versatility of many analytical methods.71  
Derivatization can be used to add charges to peptides to improve ionization or to facilitate 
dissociation or formation of specific types of fragment ions.72–74 Topologies and 
conformations of proteins can be elucidated by tagging proteins in solution and 
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quantitative tracking the tags on the resulting peptides after proteolysis. 68,75–78 The 3D 
structure obtained from such studies is a low resolution model of proteins surface based 
on the reaction efficiency at particular amino acids and positions of those same amino 
acids in the tertiary arrangement of the protein.79 Furthermore, incorporation of isotopic 
labels have proven effective for quantification. Proteins are labeled with isobaric tags that 
yield reporter ions upon peptide fragmentation whose abundances reflect the relative 
amounts of the precursor proteins.80–82 Finally, selective tagging strategies have been used 
to tune fragmentation for improved de novo sequencing which will be addressed in 
section 1.3.1 of the introduction and in Chapters 3, 4, and 5. 
1.3.1 Derivatization for De Novo Sequencing 
For de novo sequencing the quality of MS/MS spectra is key to obtaining reliable 
results. Ideal spectra for a de novo type of analysis will have very few missed peptide 
backbone cleaves so as to give a complete series of fragment ions. The spectra would also 
be devoid of any type of neutral losses such as loss of water, ammonia, or amino acid 
side-chain cleavages as these losses are less informative or even redundant and only 
complicate spectra. With this goal in mind, various derivatization methods have been 
employed to create simplified spectra specifically for de novo sequencing. A few of these 
techniques target the C-terminus for derivatization. One such example is the attachment 
of a phosphonium reagent which biases fragmentation towards b ions.83,84 In general, the 
vast majority of these methods target the N-terminus for modification as the primary 
amine presents an easy reaction site.  
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Derivatization methods that modify the N-terminus to create ideal spectra for de 
novo sequencing do so by modifying one series of fragment ions so that it can be easy 
differentiated from the other or by removing one series of ions altogether. Schemes that 
alter the isotopic distributions of a series of ions so they are easy to differentiate are 
currently the most successful example of the former. For example N-termini have been 
labeled with bromine tags so that when dissociation is performed any N-terminal ions 
will have a bromine isotope pattern making them easy to identify.85 A different strategy 
has taken advantage of the more basic N-termini as the result of a Lys-N digestion as well 
as dimethyl isotope labeling to again allow N-terminal fragments to be easily identified 
due to the isotopic pattern.86  
Despite the success of such methods the option of completely removing a series 
of ions from a MS/MS spectra has garnered the most attention over the years. One of the 
earliest reported strategies relied on modification of the N-terminus of peptides with a 
sulfonic acid group which caused N-terminal product ions to be neutralized when CID 
was performed.87,88 Another  method promoted the generation of yn-1 ions through  
amidination of the N-terminus.89,90 Similar to the amidination of peptides, the addition of 
a sulfonate to the N-terminus coupled with ETD and infrared multiphoton dissociation 
also yield simplified MS spectra. 91–93 Acetylation has also been used as viable means to 
suppress b ion formation.94 The combination of Lys-N digestion and imidazolinylation of 
the N-terminus of peptides resulted in formation of triplet sets of ions, when fragmented 
with 193 nm UVPD, creating spectra that were ideal for de novo sequencing.95 Also, as 
discussed briefly in section 1.2.4 of the introduction, UV chromophores have been 
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attached to the N-terminus of peptides resulting in a single series of ions to be produced 
when subjected to 355 nm UVPD.70 The numerous approaches to simplifying MS/MS 
spectra clearly show the advantage that can be gained from performing de novo 
sequencing in such a way, however such approaches remain underutilized in the field of 
proteomics. One of the major challenges facing the widespread implementation of such 
schemes is the lack of appropriate algorithms to exploit the unique spectra these methods 
produce. This dissertation will discuss the use of a de novo program that takes advantage 
of the benefits offered by such MS/MS spectra. 
1.4 CHAPTER OVERVIEW:  
This dissertation aims to create a de novo sequencing method that uses 
derivatization as well as the unique fragmentation generated by 351 nm UVPD. 
Furthermore, the use and optimization of a program that capitalizes on this unique 
dissociation is discussed. It will also focus on further understanding the unique 
fragmentation offered by different forms of UVPD. 
In Chapter 3, a method is developed in which the N-terminus of peptides are 
modified with a UV chromophore that when exposed to 351 nm UV light causes 
fragmentation as well as the annihilation of b-ions leaving a clean series of y-ions that are 
ideal for de novo sequencing. The method is shown to be applicable for analysis of single 
proteins as well simple mixture of proteins, and finally is used to differentiate between 
several different green fluorescent protein (GFP) variants. 
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Chapter 4 improves upon this method by adapting it for analysis of complex 
mixtures of proteins from cell lysates. In order to take full advantage of results the design 
and optimization of new de novo sequencing algorithm was also undertaken. The effect 
of combining simplified fragmentation spectra from the 351 nm UVPD method and the 
de novo program resulted in a new de novo strategy that outperforms or is on par with 
current analysis software even when limited to low resolution data.  
In Chapter 5 the 351 nm UVPD de novo method is altered to allow hybrid de novo 
searches to be performed with the use of sequencing tags and a database analysis. A 
UVPD/CID hybrid activation method is implemented, allowing paired spectra to be 
searched and enabling improved confidence of de novo results by taking advantages of 
UVPD and CID spectra together. 
Chapters 4 and 5 entailed long-term collaborations with Prof. Edward Marcotte’s 
group. In particular, Andrew Horton was responsible for the design, construction, and 
optimization of the de novo sequencing algorithm (UVNovo).   
Finally, a fundamental study of 266 nm UVPD fragmentation was undertaken in 
Chapter 6. For this study all of the different charge states for six peptides were 
investigated in order to better understand 266 nm UVPD fragmentation based on charge 
state and amino acid composition. These results were compared to fragmentation from 
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2.1 MASS SPECTROMETRY 
All work in this dissertation entailed the use of an ion trap mass spectrometer 
modified for implementation of photodissociation. In many cases, peptides were 
derivatized prior to analysis, and these methods are described in this chapter. A Thermo 
Velos Pro dual linear ion trap mass spectrometer (Thermo Fisher, San Jose, CA) was 
used for all experiments. The dual linear ion trap configuration consists of a high pressure 
cell, which is used for collisional cooling of ions (allowing for more efficient trapping) 
and fragmentation via collision induced dissociation (CID), and a low pressure cell 
typically used for mass analysis. A modification to the back of the instrument allows 
ultraviolet photodissociation (UVPD) to be carried out in either of these two ion traps. 
The automatic gain control (AGC) was set to 1E4, and the heated capillary temperature 
was maintained at 275 °C. Standard parameters (q-value of 0.25) were used for CID. 
Three different types of UVPD were used in conjunction with the Velos Pro and 
performed in the low pressure trap. For 193 nm and 351 nm UVPD a Coherent Excistar 
excimer laser (Santa Clara, CA) was used with ArF (193 nm) or XeF (351 nm) as the 
excitation gas, respectively. For 193 nm UVPD the activation period was 4 ms (2 laser 
pulses), whereas the 351 nm UVPD activation period ranged from 4 ms to 50 ms (2 to 25 
laser pulses). For 266 nm UVPD a Continuum Minilite Nd:YAG laser (Santa Clara, CA, 
USA) was used and  the activation period ranged from 2 ms to 670 ms (1 to 10 laser 
pulses).  
Samples are introduced to the mass spectrometer via electrospray ionization (ESI) 
which allows peptides and proteins to be gently ionized with little degradation. In order 
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for ionization to occur a sampled is flowed through a narrow capillary and high voltage is 
applied to the solution. The resulting charged spray yields multiply charged ions of the 
analyte of interest. For the experiments in this dissertation two types of ESI were used: 
traditional ESI and nanoESI. NanoESI utilizes smaller capillaries which allow for 
flowrates in the nL/min range and require significantly lower voltage to be applied. The 
lower flowrate offers better sensitivity for data collection. For traditional ESI, flowrates 
of 3 to 5 µl/min and a high voltage of 5 kilovolts were used to generate ions. The flowrate 
used for nanoESI experiments was set to 300 nL/min and the applied voltage was 2 
kilovolts. Proteins and peptides were infused at concentrations between 1 and 10 µM in 
49:50:1 H2O/acetonitrile/formic acid (v/v/v) or 70/30 H2O/acetonitrile. 
2.2 LIQUID CHROMATOGRAPHY 
A Dionex Ultimate 3000 nanoLC system (ThermoFisher Scientific; San Jose, CA) was 
used for the analysis of all complex proteolytic digests. The sample was first loaded onto 
a trap column via a loading pump. The trap column was packed with 5 µm Michrom 
Magic C18 from Bruker-Michrom (Auburn, CA) to a length of approximately 3 cm. The 
loading pump delivered a solution of 97.9/2/0.1 H2O/acetonitrile/formic acid (v/v/v) at 5 
µL/min for 5 min. The trap column was then placed in line with the analytical column. 
The analytical column was a New Objective PicoFrit capillary (Woburn, MA) (75 μm x 
15 cm) packed with 3 μm Michrom Magic C18 from Bruker-Michrom (Auburn, CA). For 
separation, mobile phase A consisted of 0.1% formic acid in water and mobile phase B 
was 0.1% formic acid in acetonitrile. For analysis of single protein digests and simple 
mixtures 1 μg of sample was injected and the gradient for the analytical column was 
started at 3% B then increased to 50% B over 120 min at a flow rate of 300 nL/min.  For 
complex mixtures (e.g. whole cell lysate) 5 μg of sample was injected and the gradient 
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was started at 3% B then increased to 50% B at 300 nL/min over 360 min via a slower 
gradient to account for increased sample complexity.  
2.3 CHEMICALS 
Bovine serum albumin, cytochrome C (bovine), beta-lactoglobulin (bovine), 
carbonic anhydrase (bovine) as well as O-methylisourea, iodoacetamide (IAM), and 
dithiothreitol (DTT) were purchased from Sigma-Aldrich (St. Louis, MO, USA). Peptides 
ASHLGLAR and TSTEPQyQPGENL were purchased from Anaspec (Fremont, CA). 
ACTH (1-10, sequence SYSMEHFRWG), ACTH (1-14, sequence 
SYSMEHFRWGKPVG), ACTH (1-16, sequence SYSMEHFRWGKPVGKK), ACTH 
(1-17, sequence SYSMEHFRWGKPVGKKR), ACTH (1-24, sequence 
SYSMEHFRWGKPVGKKRRPVKVYP), ACTH (1-39, sequence 
SYSMEHFRWGKPVGKKRRPVKVYPNGAEDESAEAFPLEF), were purchased from 
American Peptide Company (Sunnyvale, CA, USA). HPLC grade water, phosphate 
buffered saline (PBS), ammonium bicarbonate, and dimethyl sulfoxide were purchased 
from Thermo Fisher Scientific Inc. (Waltham, MA). Mass spectrometry grade trypsin-
gold was purchased from Promega (Madison, WI, USA). LC-MS grade formic acid was 
purchased from Fisher scientific (Fair Lawn, NJ). LC-MS grade acetonitrile and water 
were purchased from EMD Millipore (Darmstadt, Germany). Sulfosuccinimydyl-7-
amino-4-methyl-coumarin-3-acetic acid (AMCA) was purchased from Pierce 
Biotechnology (Rockford, IL, USA). E.coli lysate was graciously donated by Dr. Stephen 
Trent  at the University of Texas at Austin. 
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2.4 PREPARATION OF AMCA MODIFIED SAMPLES 
2.4.1 Peptide Samples 
For peptide reactions, 25 μL of a 1 mM peptide solution as well as 2.5 μL of 20 
mM  sulfo-NHS AMCA (in DMSO) were added to 270 μL of PBS. The mixture was 
reacted overnight in the dark at room temperature and then was cleaned up using a home 
packed C18 SPE cartridge. The modified peptides were eluted from the SPE cartridge 
with 70/30 acetonitrile/water and constituted to a final concentration of 10 μM. 
2.4.1 Proteins: Guanidination 
For each protein, 34 μL of a 100 μM protein solution was diluted in 150 μL of 100 
mM ammonium bicarbonate prior to reduction with dithiothreitol and alkylation with 
iodoacetamide. Next the protein was digested with trypsin (1:20 w/w ratio) via incubation 
at 37 °C overnight. The digest was cleaned up using a C18 SPE cartridge and dried using 
a Savant DNA120 speedvac concentrator (Thermo Electron, Waltham, MA). The dried 
protein digests were then reconstituted in 50 μL of 7 N ammonium hydroxide prior to 
guanidination of the peptides. Guanidination was performed to convert the amine side-
chains of lysines to unreactive homoarginine groups in a manner described previously 
(Reaction scheme shown in Figure 2.1a).1 Briefly 15 μL of a 1 mg/mL O-methylisourea 
solution was allowed to react with 50 μL of 68 μM solution of the protein digest for 10 
min at 65 °C. The resulting peptides were again cleaned up with a C18 SPE cartridge and 
dried via speedvac. The dried guanidinated digest was reconstituted in 270 μL of 1× PBS. 
A volume of 15 μL of 20 mM sulfo-NHS AMCA was then added and allowed to react 
overnight at room temperature (Reaction scheme shown in Figure 2.1c). The reaction 
was cleaned up with a C18 SPE cartridge and dried by a speedvac. Once dried, the 
modified digests were reconstituted in LC solvents. 
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Figure 2.1: a) Reaction scheme for guanidination of lysine side chains. b) Reaction 
scheme carbamylation of lysine side chains. c) Reaction scheme for 
modification of peptide N-terminus with AMCA. 
 
2.4.2 Proteins: Carbamylation 
For model proteins and E. coli lysate, 50 μg of the protein or lysate in 100 μL of 
50 mM sodium carbonate and 8 M urea was heated at 80 °C for 4 hours in order to block 
all primary amines via carbamylation to prevent reaction with AMCA (Reaction scheme 
shown in Figure 2.1b). After carbamylation, proteins were buffered exchanged into PBS 
to remove urea, DTT, and IAM.  Proteins were digested using trypsin (1:20 w/w ratio) at 
37 °C overnight.  After digestion, 25 µL of 20 mM AMCA in DMSO was added to the 
270 μL of the digest and incubated in the dark overnight at room temperature (Reaction 
scheme shown in Figure 2.1c). Following modification with AMCA samples were 
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cleaned using a C18 SPE cartridge, evaporated to dryness, and reconstituted in LC 
solvents. 
2.5 ULTRAVIOLET PHOTODISSOCIATION 
For all types of UVPD used in this dissertation a Thermo Velos Pro dual linear 
ion trap mass spectrometer (Thermo Scientific; San Jose, CA) was outfitted with an 
appropriate laser to allow for 193 nm, 266 nm, or 351 nm photons to be transmitted in the 
linear ion trap via a CaF2 window (for 193 nm and 266 nm) or a fused silica window (for 
351 nm) as described previously.2 
2.5.1 UVPD at 193 nm 
For 193 nm UVPD a Coherent Excistar excimer laser (Santa Clara, CA) was used. 
The laser was pulsed twice per scan with an energy of 2 mJ and a pulse duration of 5 ns 
at a frequency of 500 Hz. 
2.5.2 UVPD at 266 nm 
For 266 nm the Velos Pro was equipped from a Continuum Minilite Nd:YAG 
laser (Santa Clara, CA, USA) for UVPD. The laser was pulsed 1, 2, 5, or 10 times with 
an energy of 6 mJ per photon at a frequency of 10 Hz. 
2.5.3 UVPD at 351 nm 
For 351 nm UVPD a Coherent Excistar excimer laser (Santa Clara, CA) was used. 
The laser was set to 3 mJ per pulse at 500 Hz and delivered 2, 5, 10, 15, 20, or 25 pulses 
per scan. For LC MS/MS experiments 351 nm UVPD was performed by setting the laser 
to 3 mJ and 15 pulses per scan. A data dependent method was used in which the first scan 
was a full mass scan (m/z range of 400-2000) followed by ten MS/MS events where 
UVPD was performed on the ten most abundant ions from the full scan. For CID/UVPD 
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LC MS/MS experiments the first event was again a full mass scan (m/z 500-2000) 
however this was followed by alternating CID/UVPD events where CID and UVPD were 
performed back to back on the five most abundant peaks from the full mass scan event. 
 
2.6 AUTOMATED DATABASE SEARCHING 
2.6.1 SEQUEST 
SEQUEST, operated through Proteome Discoverer v. 1.3 (ThermoFisher 
Scientific, San Jose, CA), was used to evaluate the improvement of sequence assignment 
for spectra featuring y ions. SEQUEST settings were altered for AMCA-modified digests 
so that only y ions were considered. AMCA was added to the database as a custom 
modification which could be added to the N-terminus of any peptide or any lysine. 
Standard settings (precursor mass tolerance 1.6 Da, fragment mass tolerance 0.8 Da, and 
2 missed cleavages) were used for database searches of protein digests based on CID 
mass spectra; however, the SEQUEST settings were altered for the UVPD data sets. The 
International Protein Index (IPI) bovine database was used as the database for the 
SEQUEST searches. 
In order to obtain a list of true peptides from the E.coli lysate SEQUEST, run 
through Proteome Discoverer v. 1.4 (ThermoFisher Scientific, San Jose, CA) was used. 
AMCA was added as a fixed modification on the N-terminus of all peptides. SEQUEST 
was set up with standard settings except that lysine cleavage of trypsin was disabled by 
selecting Trypsin(R) in the settings. The reason lysine cleavage was disabled is because 
carbamylation of lysines prevents trypsin from cleaving at lysines. The search was set so 
that b-ions would not be considered and only y-ions would be searched  for UVPD data 
sets. The database used was an E. coli reference database from UniProt. CID/UVPD 
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E.coli datasets were also searched using SEQUEST with all parameters the same except 
both b and y ions were searched to ensure proper results for CID. 
2.6.2 PEAKS 
PEAKS 6 (Bioinformatics Solution Inc.; Waterloo, ON, Canada) was used for de 
novo sequencing of the protein digests. Raw files were converted into mzXML and then 
imported into the PEAKS database. Standard ion trap search parameters were used for 
both de novo and database comparison sections. The AMCA modification was added to 
the PTM section of the database in two ways: as a modification at the N-terminus and as 
a modification at lysines. The modification at lysine was added to ensure that if a lysine 
was not guanidinated, the peptide would not give false identification of an AMCA 
modification at the N-terminus. After completion of the PEAKS processing, the results 
were then checked against the International Protein Index (IPI) bovine database, allowing 
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  De Novo Sequencing of Peptides Using Selective 351 nm Ultraviolet 
Photodissociation Mass Spectrometry1 
3.1 OVERVIEW 
Although in silico database search methods remain more popular for shotgun 
proteomics methods, de novo sequencing offers the ability to identify peptides derived 
from proteins lacking sequenced genomes and ones with subtle splice variants or 
truncations. Ultraviolet photodissociation (UVPD) of peptides derivatized by selective 
attachment of a chromophore at the N-terminus generates a characteristic series of y ions. 
The UVPD spectra of the chromophore-labeled peptides are simplified and thus 
amenable to de novo sequencing. This method resulted in an observed sequence coverage 
of 79% for cytochrome C (eight peptides), 47% forβ-lactoglobulin (five peptides), 25% 
for carbonic anhydrase (six peptides), and 51% for bovine serum albumin (33 peptides). 
This strategy also allowed differentiation of proteins with high sequence homology as 
evidenced by de novo sequencing of two variants of greenfluorescent protein 
3.2 INTRODUCTION 
Technological advances in tandem mass spectrometry, including improvements 
related to sensitivity, high resolution and high mass accuracy performance metrics, 
quantitative abilities, and ion activation methods, have accelerated the routine 
                                                 
1 Robotham, S. A.; Kluwe, C.; Cannon, J. R.; Ellington, A.; Brodbelt, J. S. De Novo 
Sequencing of Peptides Using Selective 351 nm Ultraviolet Photodissociation Mass 
Spectrometry. Anal. Chem. 2013, 85 (20), 9832–9838. 
(Scott A Robotham preformed mass spectrometry experiments, sample preparation, and 
wrote the article. Christien Kluwe created and provided green fluorescent protein 
samples. Joe R Cannon helped preform data analysis of mass spectrometry results. 
Andrew Ellington supervised the creation of the protein samples. Jennifer S Brodbelt 
supervised the mass spectrometry experiments.) 
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identification of proteins and applications to large scale proteomics.
1
 The most common 
strategy is the bottom-up approach which entails proteolytic digestion of proteins prior to 
chromatographic separation of the resulting peptides and identification based on their 
MS/MS fragmentation patterns.  The MS/MS patterns are matched to predicted tandem 
mass spectra from a protein database (an in silico method) or directly interpreted based 
on the masses and mass differences of the fragment ions (de novo sequencing).  The 
former method has been the dominant one used because of the tremendously powerful 
algorithms developed to exploit the enormous amount of genomic sequence information 











 among others.   Despite their widespread popularity, these in 
silico database search algorithms are limited to the identification of proteins  from 
organisms with sequenced genomes and often yield less successful results for proteins 
incorporating post-translational modifications.
7
 A similar deficiency arises for 
identification of splice variants, mutants, and truncated proteins.   
  The shortcomings of the general database search approach has spurred the 
development of de novo sequencing methods
8–10
  which offer greater flexibility for 
mapping unexpected post-translational modifications and sequence mutations. There 
have been many de novo programs developed to facilitate interpretation of peptide 

















 among others   Since 
de novo sequencing relies on the direct interpretation of the peptide fragmentation 
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patterns to assign sequences, the ideal MS/MS spectra should exhibit few missed 
cleavages while affording consistent series of fragment ions without extensive secondary 
neutral losses of water, ammonia, or side-chain groups. Some of the algorithms perform 
optimally for more simplified MS/MS patterns that do not contain redundant ions series, 
such as solely N-terminal b ions or C-terminal y ions, and thus utilize only a single ion 
type to construct sequence tags. Others use all ion types in conjunction with high mass 
accuracy information to create more elaborate connections of sequence tags
18,19
 
 With respect to generation of diagnostic fragmentation patterns of peptides, 
collisional induced dissociation (CID) is the gold standard for producing spectra 
containing primarily b and y ion series. 
20,21
 Other methods such as electron-based 
activation methods (electron capture dissociation ECD
22
 and electron transfer 
dissociation ETD
23,24
), surface induced dissociation (SID),
25
  and photodissociation 
(PD)
26–29
 have gained traction in recent years to complement CID and overcome some of 
its limitations.  For example, the electron-based methods are well-known for facilitating 
mapping of PTMs.  To compensate for incomplete ion series in CID spectra during de 
novo sequencing applications,  ETD spectra have been integrated with CID spectra to 
improve sequencing accuracy.
30 
Both SID and PD afford richer MS/MS spectra than CID, 
and in particular UVPD results in informative a/x fragmentation patterns for peptide 
anions, a particular shortcoming of CID.
31
 Each UV photon deposits considerable energy 
(i.e. 157 nm is 7.9 eV, 193 nm is 6.4 eV, 266 nm is 4.7 eV, and 351 nm is 3.5 eV), and 




  Reilly et al. has explored UVPD at 157 nm to generate rich fragmentation 
patterns that have been used for de novo sequencing.
50,51
  UVPD at 193 nm similarly 
results in extensive peptide backbone cleavages that lead to a large array of fragment 
ions.
31–37
 We have integrated 193 nm UVPD with Lys-N proteolysis for de novo 
sequencing based on the formation of series of triplet N-terminal ions (a,b,c) .
52
  
 Since many of the de novo algorithms exhibit superior performance for MS/MS 
spectra containing well-defined fragment ion series, there have also been numerous 
efforts to tailor ion activation to optimize peptide dissociation. Most activation methods 
of native peptides give both N-terminal and C-terminal ions,
20,21,53,54
  but strategic 
derivatization methods have been developed to enhance specific series of fragment ions 
or eliminate others.
48,50,52,55–72
   For example Keough et al. were one of the first groups to 
show that derivatizing the N-terminus of peptides with an ionizable sulfonic acid group 
resulted in neutralization of N-terminal product ions formed during CID (for singly 
charged precursors), thus  leaving only the C-terminal  y series as detectable charged 
fragment ions.
55,56
 The success of simplifying de novo sequencing by eliminating a 
complete ion series motivated others to adopt and further refine this approach. In this 
context, Reilly et al. developed an N-terminus amidination procedure that promoted the 
production of yn-1 ions.
60,61
 Our group has adapted a similar N-terminal sulfonation 
method for use with alternative activation methods including ETD and IRMPD.
62–64
 Lee 
et al. demonstrated that isotopically-labeled sulfonation reagents allowed facile 




 Similar to this latter method, Kim et al. labeled the N-terminus of 
peptides with a bromine tag so that these N-terminal peptides fragments could be easily 
distinguished from C-terminal fragments owing to the presence of the bromine isotope 
signature, thus allowing peptides to be sequenced based on the N-terminal fragments.
66
 In 
another study Samgina modified the N-terminus of peptides by 2,4,6-trimethylpyridinium 
or acetylation in order to prevent cyclization of the resulting b ions and hence improve de 
novo sequencing.
67
 In an effort to bias fragmentation via creation of peptides with a basic 
N-terminus,  Boersema et al. used Lys-N to digest proteins,
68 
and the resulting peptides 
favored formation of N-terminal fragment ions upon MS/MS.   Hennrich et al. developed 
a method that also exploited Lys-N digestion in conjunction with dimethyl isotope 
labeling, ultimately resulting in N-terminal fragment readily differentiated from C-
terminal fragments based on the isotopic labeling pattern.
69
  Yamaguchi et al. 
demonstrated derivatization of the C-terminus using a fixed charge phosphonium reagent 
that facilitated production of b-type ions.
71,72
  Very recently Ji et al. reported an on-tip 
derivatization method to append fixed charges to the N-termini of peptides and then 
integrated CID and ETD spectra to increase the confidence of the identified sequences 
based on more comprehensive N-terminal fragment maps.
73 
 In a rather different 
approach that harnessed the selectivity of UVPD, we reported that the attachment of a 
UV chromophore to the N-terminus of a peptide resulted in almost exclusive product ion 
of  y ions upon UVPD at 355 nm, as the chromophore-labelled b ions were selectively 
 46 
annihilated upon multiple UV laser pulses.
48
 Similarly, modification of the C-terminus 
instead of the N-terminus led to detection  of a- and b-type ions upon UVPD.  
 
The ability to tailor the fragment ion series motivated our interest to adapt the 
chromophore-mediated UVPD approach for de novo sequencing in the present study. 
Here we report a strategy that utilizes UVPD at 351 nm to selectively activate and 
dissociate tryptic peptides labeled at their N-termini with chromophores. The advantage 
of using radiation around 350 nm is that this wavelength range is not absorbed by native 
peptides, thus affording high selectivity for only those peptides modified with a suitable 
UV chromophore. Moreover, upon photoirradiation the chromophore-labeled fragment  
ions (e.g. b ions in the present study due to the N-terminal tagging procedure) are 
selectively annihilated, whereas the non-absorbing y ions survive as stable product ions.  
The resulting MS/MS spectra exhibit complete series of y ions, making them well-
adapted for de novo sequencing in LCMS workflows.  In sum, UVPD using 351 nm 
photons offers two types of selectivity: (1) only the chromophore-labelled peptides 
respond to the photoirradiation, a factor which alleviates MS/MS contributions from 
other confounding background components in the sample (i.e. precursor overlap), and (2) 
the UVPD spectra of the chromophore-labelled peptides are simplified and highly suited 
to de novo algorithms. As demonstrated in this study, a supercharged mutant green 
fluorescent protein (GFP), designed to improve reversibility of unfolding
74
, is confidently 




Peptides ASHLGLAR and TSTEPQyQPGENL were purchased from Anaspec 
(Fremont, CA, USA). The lower case “y” represents a phosphorylated tyrosine.  Proteins 
cytochrome C (bovine), bovine serum albumin, beta-lactoglobulin (bovine), carbonic 
anhydrase (bovine) as well as O-methylisourea, iodoacetamide (IAM), and dithiothreitol 
(DTT) were purchased from Sigma-Aldrich (St. Louis, MO, USA). Acetonitrile, HPLC 
grade water, phosphate buffered saline (PBS), ammonium bicarbonate, dimethyl 
sulfoxide were purchased from Thermo Fisher Scientific Inc.  (Waltham, MA, USA). 
Sulfosuccinimydyl-7-amino-4-methyl- coumarin-3-acetic acid (sulfo-NHS AMCA or 
AMCA for short) was purchased from Pierce Biotechnology (Rockford, IL, USA). 
3.3.2 Preparation of Mutant Green Fluorescent Proteins 
Green fluorescent protein mutants were prepared in the following manner. 
Plasmids encoding the GFP constructs were transformed into BL21(DE3) cells, which 
were than plated on LB+Antibiotic. pET21 expression vector with Ampicillin resistance 
was used. Single colonies were inoculated into 3 mL overnight cultures. The cultures 
were then diluted with fresh media at a ratio of 1:200 and grown to a density of 0.6-0.8. 
Cells were then induced with 1 mM IPTG and incubated for 18-22 hours at 18 °C. After 
incubation cells were spun down and resuspended in IMAC buffer supplemented with 
benzonase. The cells were then lysed by sonication and lysates cleared by centrifugation 
at 40,000xg for 30 min. Cleared lysates were loaded onto a Ni-NTA column for affinity 
purification using the hexahistidine tag. Non-specific proteins were removed by washing 
with buffers containing increasing amounts of imidazole. GFP was then eluted with high 
imidazole and dialyzed 10 mM Tris, 1 mM EDTA (pH 8.0). 
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3.3.4 Modification of Peptides and Proteins  
For peptide reactions 25 µL of a 1 mM peptide solution as well as 2.5 µL of 20 
mM sulfo-NHS AMCA (in DMSO) were added to 270 µL of PBS. The mixture was 
allowed to react overnight in the dark at room temperature and then was cleaned up using 
a home packed C18 SPE cartridge. The modified peptides were eluted from the SPE 
cartridge with 70/30 acetonitrile/water, and constituted to a final concentration of 10 µM. 
For each protein, 34 µL of a 100 µM protein solution was diluted in 150 µL of 100 mM 
ammonium bicarbonate prior to reduction with dithiothreitol and alkylation with 
iodoacetamide. Next the protein was digested with trypsin via incubation at 37 °C 
overnight. The digest was cleaned up using a C18 SPE cartridge, and dried using a 
Savant DNA120 speedvac concentrator (Thermo Electron, Waltham, MA, USA). The 
dried protein digests were then reconstituted in 50 µL of 7 N ammonium hydroxide prior 
to guanidination of the peptides. Guanidination was performed to convert the amine side-
chains of lysines to unreactive homoarginine groups.  In order to guanidinate the digested 
peptides, 15 µL of a 1 mg/µL O-methylisourea solution was allowed to react with 50 µL 
of 68 µM solution of the protein digest for 10 min at 65 °C. The resulting peptides were 
again cleaned up with a C18 SPE cartridge and dried via speedvac. The dried 
guanidinated digest was reconstituted in 270 µL of 1x PBS. 15 µL of 20 mM sulfo-NHS 
AMCA was then added and allowed to react overnight at room temperature, resulting in 
coupling of the sulfo-NHS-AMCA to the N-terminal amine group (Scheme 3.1). The 
reaction was cleaned up with a C18 SPE cartridge and dried by a speedvac. Once dried 





Scheme 3.1: Modification of N-terminus of peptides by AMCA. 
 
3.3.5 MS analysis of Modified Peptides 
A Thermo Velos Pro dual linear ion trap mass spectrometer (Thermo Scientific; 
Waltham, MA, USA) was modified to allow introduction of a laser beam through an 
optical port in a manner similar to that described previously.
75 
A Coherent 351 nm 
excimer laser (Coherent; Santa Clara, CA, USA) was used for UVPD. The laser was set 
to 3 mJ per pulse at 500 Hz, and the number of pulses was varied from 2 to 25 pulses to 
optimize UVPD. For all peptides both CID and UVPD experiments were carried out in 
order to compare the contributions from  b/y ions to the MS/MS spectra. For CID a 
normalized collision energy (NCE) of 35% was used, with an activation time of 10 ms 
and a q value of 0.25. Peptides were infused by ESI at 5 ul/min in the positive mode..  
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3.3.6 LCMS/MS analysis of Modified Proteins   
For modified protein digests, the same sets of UVPD and CID parameters were 
used as described above.  HPLC separation was carried out using a Dionex NSLC 3000 
nanoLC system (Thermo Scientific; Waltham, MA, USA) which was interfaced to the 
Velos Pro mass spectrometer.  Fifteen laser pulses (at 500 Hz) were used per scan.  The 
LC gradient consisted of mobile phase A: water with 0.1% formic acid and mobile phase 
B: acetonitrile with 0.1% formic acid. The loading solvent used was 98% water/2% 
acetonitrile with 0.1% formic acid. For each run 1 µL of the sample was injected and 
loaded on to a trap column prior to separation and elution from the analytical column. 
The column was produced in-house using a New Objective PicoFrit analytical column 
(Woburn, MA) (75 µm x 15 cm) and packed with 3 µm Michrom Magic C18 from 
Bruker-Michrom (Auburn, CA, USA).  The gradient started at 3% B and increased to 
50% B over 120 min at a flow rate of 300 nL/min. Companion LC-MS/MS experiments 
were undertaken using CID to allow comparisons to UVPD. 
3.3.7 PEAKS analysis 
PEAKS 6 (Bioinformatics Solution Inc.; Waterloo, ON, Canada) was used for  de 
novo sequencing of the protein digests. Raw files were converted into mzXML and then 
imported into the PEAKS database. Standard ion trap search parameters were used for 
both de novo and database comparison sections. The AMCA modification was added to 
the PTM section of the database in two ways:  as a modification at the N-terminus and as 
a modification at lysines. The modification at lysine was added to ensure that if a lysine 
was not guanidinated, the peptide would not give false identification of an AMCA 
modification at the N-terminus. After completion of the PEAKS processing, the results 
were then checked against the International Protein Index (IPI) bovine database, allowing 
identification of peptides corresponding to the proteins. In order to check the results 
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obtained for the mutant green fluorescent proteins, the sequences of all mutants were 
added to a modified IPI bovine database and subsequently searched. 
3.3.8 SEQUEST analysis 
SEQUEST, run through Proteome Discoverer v. 1.3 (ThermoFisher Scientific, 
San Jose, CA), was used to evaluate the improvement of sequence assignment for spectra 
featuring y ions. Standard settings were used for database searches of protein digests 
based on CID mass spectra; however, the SEQUEST settings were altered for the UVPD 
data sets acquired for the AMCA-modified digests so that only y ions were considered. 
The International Protein Index (IPI) bovine database was used as the database for the 
SEQUEST searches. 
3.4 RESULTS 
3.4.1 351 nm UVPD of Modified Peptides 
The streamlined de novo strategy described in this report hinges on the fact that 
351 nm light is not absorbed by native peptides, thus providing the basis for the selective 
UV photoactivation of modified peptides and preferential annihilation of the 
chromophore-labelled sequence ions (e.g. the N-terminal ions in the present study).  
Modification of the N-termini of peptides is readily accomplished via in-solution 
derivatization with the sulfo-NHS-AMCA reagent (Scheme 3.1).  To illustrate the 
selective photodissociation of chromophore-labelled peptides, the UVPD mass spectra of 
unmodified and AMCA-modified peptides were compared. The comparison of one such 
model peptide is shown in Figure 3.1. From this comparison it is evident that unmodified 
peptides do not dissociate upon irradiation with 351 nm photons (Figure 3.1A), thus 
demonstrating the poor intrinsic absorption coefficient of peptides at this wavelength. 
The corresponding AMCA-modified peptide not only undergoes extensive 
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photodissociation (Figure 3.1B) but also exhibits a dominant series of y ions, but no or 
low abundance b ions.  The location of the AMCA chromophore at the N-terminus 
renders the b ions highly susceptible to UVPD, thus eliminating them from the spectrum. 
It should also be noted that when histidines are present in the peptide sequences, low 
abundance internal and immonium ions are observed in some of the resulting MS/MS 
spectra (see H, SH, and HGL ions labeled in Figure 3.1B). These internal ions are only 
observed at lowerm/zvalues and thus do not cause a significant impediment for de novo 
sequencing. Such internal ions should be considered when analyzing 351 nm UVPD mass 




Figure 3.1: UVPD of a. ASHLGLAR (2+) and b. ASHLGLAR modified with AMCA 
(2+). 15 pulses at 3 mJ was used to induce fragmentation. Internal fragments 
H, SH, and HGL are shown.  The precursor ion is labeled with an asterisk. 
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Implementation of the UVPD/de novo strategy on an LC time-scale required 
optimization of the number of laser pulses and laser power to maximize dissociation 
efficiency , the annihilation of b ions, and the overall throughput. To achieve this 
optimization, the UVPD spectra of two AMCA-modified peptides, ASGLGALR and 
TSETPQySPGENL,  were monitored as a function of laser power and number of pulses.  
The outcomes of the pulse-variable experiments are shown in Figure 3.2.  The 
abundances of all b and y ions from each number of pulses were tallied and used to 
calculate the b/y distributions as percentages in Figure 3.2.  Even at a low number of 
pulses, y ions are clearly favored.  As the number of laser pulses increased, the 
percentage of b ions decreased.  For both peptides the portion of y ions plateaued after 15 
pulses, and there was no significant gains using a greater number of laser pulses.  In light 
of these results, 15 pulses were chosen for all UVPD experiments.  At a laser repetition 
rate of 500 Hz this means that the total activation period required for 15 pulses is 30 
msec.  A similar procedure was undertaken to optimize the laser power, and 3 mJ was 
found to be ideal for producing a rich array of y ions and substantial elimination of b 





Figure 3.2: Bar graphs illustrating the decrease in the relative abundances of b ions as 
the number of laser pulses increase for peptides modified with AMCA. A) 
ASHLGLAR (2+) B) TSTEPQyQPGENL (2+) 
3.4.2 De novo Sequencing of Model Proteins 
The UVPD method was evaluated for de novo sequencing of tryptic peptides from 
selected proteins, as illustrated for bovine cytochrome c in Figure 3.3.  In this case, 
cytochrome C was digested with trypsin, followed by guanidination of the epsilon-amine 
groups of the side-chains of lysines.  Guanidination was undertaken to deactivate the 
lysine amines from subsequent reaction with sulfo-NHS-AMCA. The guanidination 
reaction efficiency was estimated to be greater than 95%.  After guanidination the digest 
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was modified with sulfo-NHS-AMCA, then analyzed by LCMS with ion fragmentation 
by either CID or UVPD in order to compare the two MS/MS methods for de novo 




Figure 3.3: Comparison of sequence ions seen for AMCA-TGPNLHGLFGR (2+) from 
the cytochrome C digest by  a. CID and b. UVPD (15 pulses, 3 mJ). Internal 
ions LHG and LHGL are shown so that the abundance of internal fragments 
can be seen. The precursor ion is labeled with an asterisk. 
Figure 3.3 shows a comparison of the CID and UVPD spectra of one tryptic peptide 
TGPNLHGLFGR.  The CID spectrum displays the expected series of both b and y ions 
(with retention of the AMCA tag on all the b ions), whereas the y ion series dominates 
the UVPD spectrum.  Two products observed in all of the UPVD spectra of the sulfo-
NHS-AMCA-modified peptides arise from elimination of the AMCA moiety (-215 Da as 
a neutral loss) and formation of an AMCA reporter ion (m/z 216).  These two resulting 
ions are common to all the UVPD spectra of the AMCA-modified peptides and thus can 
be used to assist in pinpointing and differentiating with confidence the AMCA-modified 
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tryptic peptides from other species that might overlap in the chromatographic separation 
of complex mixtures.   The addition of the AMCA modification causes one other 
noteworthy change:  it shifts the retention time of each peptide by 10 minutes on average 
in comparison to the analogous unmodified peptide. This shift is caused by an increase of 
hydrophobicity upon addition of the non-polar aromatic chromophore to the N-terminus.  
This shift in retention disperses the peptides more broadly throughout the elution profile 
and also leads to higher ionization efficiencies in most cases due to the increasing organic 
content of the spray.    
The AMCA modification procedure was carried out for four model proteins 
(BSA, carbonic anhydrase, beta-lactoglobulin, and cytochrome C) after tryptic digestion 
and guanidination. The resulting LC-UVPD-MS data was submitted to PEAKS6 analysis 
for de novo sequencing of the individual proteins. For cytochrome C eight peptides were 
identified through de novo sequencing, giving a sequence coverage of 79%. A total of 33 
peptides were identified for BSA, accounting for a sequence coverage of 51%. Carbonic 
anhydrase showed a total of six peptides identified with a net sequence coverage of 25%, 
and five peptides were found for beta-lactoglobulin to give a sequence coverage of 47% 
(Figure 3.4). A similar LC-UVPD-PEAKS strategy was likewise  
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Figure 3.4: PEAKS results for individual AMCA-modified protein digests showing 
percent sequence coverage, number of peptides identified, as well as a list of 
peptides which were identified by de novo sequencing:  a. cytochrome C,  b. 
bovine serum albumin,  c. carbonic anhydrase, and d. beta-lactogobulin. 
 
undertaken for a mixture of the same four proteins. For this mixture, four peptides were 
found for cytochrome c, thirty for BSA, eight for carbonic anhydrase, and seven for beta-
lactoglobulin which resulted in 32% sequence coverage for cytochrome C, 51% for BSA, 
34% for carbonic anhydrase, and 44% for beta-lactoglobulin (Figure 3.5).  The results 
from the protein mixture generally parallels those obtained for each individual protein 
digest; however there are a few peptides not found for both the single protein and multi-
protein mixtures.  The protein that shows the greatest discrepancy is cytochrome C in the 
protein mixture for which the number of identified peptides and net sequence coverage 
decrease by half compared to the cytochrome c digest alone.  The number of peptides and 
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sequence coverage for carbonic anhydrase increases in the multi-protein mixture 
compared to the single protein digest.   Inspection of the peptides that were not detected 
indicated that they were typically the lower abundance peptides that eluted close to other 
AMCA-labelled peptides, thus obscuring their data-dependent selection for UVPD.  
 
 
Figure 3.5: PEAKS results for multi-protein AMCA-modified protein digest. For each 
protein percent sequence coverage, number of peptides identified, as well as 
a list of peptides which were identified by de novo sequencing: a. 
cytochrome C; b. bovine serum albumin;  c. carbonic anhydrase; and  d. 
beta-lactogobulin. 
The results from the model proteins as well as the protein mixture demonstrate the 
effectiveness of this method.  In general, the AMCA-modified peptides all exhibited 
clean series of y ions  upon UVPD, whereas the analogous CID spectra display both b 
and y ions.   In two cases, better sequence coverage was obtained for the proteins when 
digested, modified and analyzed individually than when in a mixture.  Upon further 
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investigation of this finding, several factors were considered and discarded as 
contributing to this result. At first it was suspected that the AMCA modification reaction 
was not tagging all the peptides in the more complex multi-protein digests, leaving some 
of the peptides unmodified.  However, upon re-analyzing the protein mixture digests by 
using LC-CID-MS, it was clear that this was not the case, as very few unmodified 
peptides were found in the digests by CID.  This observation confirmed that poor AMCA 
reaction efficiency for the more complex multi-protein digests was not a significant 
contributing factor. Further inspection of data acquired for the modified protein digests 
by UVPD and unmodified protein digests by CID revealed that peptides most likely to be 
missed in the UVPD runs were those that had low abundances in the CID runs obtained 
for the unmodified protein digests.  This observation suggests that the multiple clean-up 
steps used to facilitate the AMCA-tagging strategy results in sample losses that are more 
detrimental for the naturally low abundance peptides. 
In light of the multiple cleanup steps needed for the AMCA/UVPD strategy, the 
coverage obtained for AMCA-modified digests might lag that of an unmodified digest 
analyzed via conventional CID, thus prompting a secondary assessment of the potential 
analytical benefits of the former. For this assessment, the UVPD data set obtained for the 
AMCA-modified digest of BSA and the corresponding CID data set of unmodified BSA 
were evaluated by SEQUEST, a database search algorithm. SEQUEST was used because 
it allows MS/MS spectra to be searched selectively based solely on y ions. For this 
comparison, posterior error probability (PEP) scores, which indicate the probability that 
an observed peptide spectral match is incorrect, were determined for the MS/MS spectra 
generated for 33 tryptic peptides from BSA based on considering b/y ions (CID spectra) 
or only y ions (UVPD spectra), as summarized in Figure 3.6. The SEQUEST search 
resulted in high sequence coverage for the CID analyses as expected, with PEP scores 
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ranging from approximately 0.005 to 0.4. With the elimination of the b-ions from the 
spectra, there is a reduction in the chance that a fragment will be identified incorrectly. 
This results in some PEP scores that are lower (more favorable) for the UVPD data, with 
PEP scores ranging from 0.0001 to 0.3. In some cases the PEP scores for the UVPD 
spectra are several orders lower than for the corresponding CID spectra. UVPD showed 
improvement in the PEP scores for 73% of the identified BSA peptides. These results 
provide evidence that the removal of confounding b ions from the MS/MS spectra may 




Figure 3.6: Comparison of PEP scores from SEQUEST search for trypsin digested 
BSA. UVPD results were scored based on only the y-ion series while CID 
results were scored based on b-ion and y-ion series. The negative natural log 
of scores is shown with higher values corresponding to higher confidant in 
peptide assignments. Negative natural log was used to allow for an easy 
comparison of results. 
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3.4.3 De novo Sequencing of Green Fluorescent Proteins. 
To demonstrate the merits of the UVPD/de novo sequencing strategy for a 
biologically relevant application, the method was used to characterize wild type green 
fluorescent protein (GFP) and a mutant (GFP 6).  GFP6 is one of fourteen different 
variants containing specific amino acid substitutions. Each variant has substantial 
sequence homology as well as unnatural sequences that make their identification difficult 
by conventional shot-gun strategies relying on database searches. GFP wild type (GFP 
WT) and mutant GFP 6 were each digested separately and modified with AMCA prior to 
analysis by LC-UVPD. The resulting de novo sequencing was carried out using the 
PEAKS program as described earlier. Seven peptides were identified from the GFP WT 
digest (summarized in Figure 3.7A), affording a sequence coverage of 29% which 
allowed confirmation as the wild type protein.  For GFP 6, ten peptides were identified 
based on UVPD/de novo sequencing, returning a sequence coverage of 31% (Figure 
3.7B).  When searched against a database comprising all the GFP variants, the ten 
peptides led to the confident identification of the mutant as green fluorescent protein 
variant 6.  
A sequence alignment for all of the GFPs is shown in Figure 3.7C. For each 
protein there are only a few amino acids that vary, so de novo sequencing offers the best 
strategy for differentiation. For the GFP WT, the threonines at positions 38 and 43 of the 
protein are the only two amino acids that distinguish this from the other variants except 
for GFP 12 (which WT differs from only by a aspartic acid at the 129 position), so 
pinpointing the sequence of the GEGEGDAT38NGKLT43LK and IELKGID129FK 
peptides are critical for identification of the protein.  GFP 6 is distinguished from the 
other variants by only a few amino acids, including aspartic acid (D) at position 101 and 
the glutamic acid (E) at position 107. This necessitates satisfactory sequence coverage of 
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this stretch, a result achieved by 351 nm UVPD of the AMCA-modified digest and 
successful identification of the TISFD101DDGTYE107TR peptide.   
 
 
Figure 3.7: Results for AMCA-modified green fluorescent protein digests. For each 
protein percent sequence coverage, number of peptides identified, as well as 
a list of peptides which were identified by de novo sequencing for   a. Wild 
Type GFP and b. GFP 6. c. Sequence alignment for all 14 GFP variants:   
changes to the amino acid sequence are shown in red and underlined. 
3.5 CONCLUSIONS 
In this study a de novo sequencing method using 351 nm UVPD and AMCA 
modification of the N-terminus of peptides was developed to generate a clean series of y 
ions to facilitate identification of proteins. Two variants of green fluorescent protein 
(wild type and a mutant) were differentiated from other variants based on this AMCA-
tagging/UVPD-MS strategy. The multiple cleanup steps necessary for implementation of 
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this method led to loss of some low-abundance peptides but still allowed the 
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  UVnovo: A Novel De Novo Sequencing Algorithm Using Single Series 
of Fragment Ions via Chromophore Tagging and 351 nm UVPD  
4.1 OVERVIEW 
E.coli lysates have been modified by the use of carbamylation and the 
attachement of a UV chromophore to the N-terminus of digested peptides so that 
ultraviolet photodissociation (UVPD) can generate clean y- ion series peptides. UVPD 
E.coli spectra are used optimize and validate a novle de novo algorithm, UVnovo, which 
uses Random Forest model and a Hidden Markov Modle (HMM) for spectral processing 
allowing for ultimately offering high confidence identification of thousands of peptides 
from an E. coli lysate. UVnovo identified 47.7% of the sequences correctly when only 
the top result was considered and 58.2% when the top three results are considered. A 
filter can be applied that remove de novo reconstructions with low scores and thus 
improves results to 67.2% for the top result and 78.4% for the top three results For over 
half of the spectra that were identified incorrectly, the de novo results disagreed with the 
true sequence by two incorrect amino acids. Andrew Horton, a doctoral student in the 
Marcotte group is credited with the design, development, optimization, and testing of the 
UVnovo algorithm. 
4.2 INTRODUCTION 
The adoption of high throughput bottom-up mass spectrometry for proteomics has 
accelerated in the past decade, largely due to increasingly sophisticated peptide spectral 
database search methods. Although not as widely used as search engines that compare 
tandem MS/MS spectra to theoretical fragmentation patterns from an in silico digested 




 De novo sequencing directly interprets MS/MS spectra based on both 
precursor mass and mass difference of fragment ions, an approach which allows 
identification of peptides from un-sequenced genomes. Since genomic sequence 
information is not required a priori, this method is ideal for proteomics in organisms or 
samples lacking genomes. In the event that gene sequences are available, de novo 
approaches are well suited for discovering unknown splice variants or other sequence 
polymorphisms that alter amino acid sequences, as well as for identifying peptides from 
unannotated parts of the genome, as in so-called proteogenomics experiments.
2
 These 
methods are also effective at in-depth characterization of proteins via bottom-up analysis.  
 Implementation of such algorithms is far from trivial and requires “ideal” MS/MS 
spectra for optimal performance. Such spectra exhibit MS/MS fragmentation spanning 
the entire peptide sequence without missed product ions and no confounding neutral 
losses of water, ammonia, or side chain groups.  Confidence in the de novo peptide match 
is further increased by creating spectra that contain only a single series of fragment ions3, 
as multiple ion types and charge states can complicate the assignment and increase the 
chance of a mislabeled fragment. A variety of different ion activation methods have been 
implemented in order to generate these ideal MS/MS spectra. Collision-induced 
dissociation (CID; the gold standard of activation methods for bottom-up proteomics),4,5 
electron transfer dissociation (ETD),6,7 and photodissociation (PD)8–10 are all commonly 
used to obtain spectra for de novo sequencing, but all of these typically yield both N- and 
C-terminal fragment ions which make de novo interpretation more challenging.  
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 Several  programs have been designed for de novo sequencing of sequences of 
peptides based on MS/MS spectra generated by collision induced dissociation (CID) and 
electron transfer dissociation (ETD).11–18 PEAKS, created by Ma et al.,12 uses a four step 
process which involves preprocessing (noise filtering, peak centering and deconvolution), 
candidate computation, refined scoring, and global and positional confidence scoring. 
Frank and Pevzner showed with PepNovo that a scoring method which accounted for 
chemical and physical rules of fragmentation resulted in some of the most impressive de 
novo results to date.14 NovoHMM, created by Fischer et al., used a generative hidden 
Markov model (HMM) to better distinguish MS/MS signal peaks from noise.15  Bren and 
Goldberg used spectral graph partitioning to create EigenMS which resulted in significant 
improvement in accuracy for QTOF data.16 Mo et al. developed a probabilistic scoring 
function with a mass array-based dynamic programming algorithm to identify peptides 
with MSNovo.17 Recently, Vonode, developed by Pan et al., was specifically designed to 
take advantage of high resolution MS/MS spectra by using a unique tag scoring and 
customized spectral graphs for de novo sequencing.18 
 There has also been a great deal of effort focused on creating “ideal” spectra for 
de novo sequencing via chemical derivatization.  Most of these methods have been 
implemented to either enhance or eliminate a particular fragment ion series19–40 in the 
quest to obtain the most informative set of product ions for de novo sequencing.  Keough 
et al. modified N-termini of peptides with a negatively charged sulfonic acid group prior 
to analysis by positive mode matrix assisted laser desorption ionization (MALDI)-MS 
and post source decay (PSD) fragmentation.  This method predominantly produced a 
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series of y ions by silencing the  N-terminal b ions which retained the charge neutralizing 
sulfonate tag.22,23 The method was later improved by Cotter and co-workers by optimizing 
the 4-sulfophenyl isothiocyante (SPTIC) reaction for MALDI-PSD.24 We have shown 
that the SPITC modification can also be effective in conjunction with other activation 
methods such as ETD and infrared multiphoton dissociation (IRMPD).29–31 Alternative 
methods of fragment ion manipulation include derivatization to increase the basicity of 
the N-terminal primary amine, thus increasing charge localization at the N-terminus and 
enhancing the production of N-terminal product ions. For example, imidazolinylation of 
LysN metalloendopeptidase peptides resulted in the formation of N-terminal “golden 
sets” (a,b,c-ions) upon 193 nm ultraviolet photodissociation (UVPD).21 Most recently  we 
have reported a de novo sequencing strategy that uses  351 nm UVPD to activate peptides 
derivatized at their N-termini with sulfosuccinimydyl-7-amino-4-methyl-coumarin-3-
acetic (AMCA) to achieve y ion series from tryptic peptides.40 Furthermore, the 
selectivity of 351 nm UVPD ensured that only AMCA-derivatized peptides underwent 
photodissociation, affording spectra that were not complicated by simultaneous activation 
and fragmentation of co-eluting background species.  
 The elimination of all fragment ions except for a single ion series reduces the 
product ion search space, which has been shown to increase confidence for matches at 
both the MS and MS/MS levels.41,42 Cannon et al. reported that reducing the MS1 search 
space by mass biased partitioning improved analyses for both middle down-sized as well 
as bottom up-sized peptides.43 Our group has also shown the effective reduction of MS1 
search space by using cysteine enrichment and UVPD; this strategy allowed us to 
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successfully analyze heavy-chain complementarity determining regions of single-chain 
antibodies.44 Hansen et al. used amino acid composition information to reduce the 
MS/MS search space, thereby increasing peptide identification confidence and lowering 
false discovery rates.45  
Even with the effectiveness of methods to simplify MS/MS spectra, none of these 
strategies have reached their full potential for de novo sequencing as currently there is no 
program able to take advantage of the benefits offered by such techniques. Here, we unite 
chemical derivitization and computational strategies into a new high throughput de novo 
sequencing method that combines a reduction in spectral complexity with a new program 
called UVnovo that uses the streamlined spectra to improve de novo sequencing. First, 
we demonstrate the near quantitative efficiency of carbamylation at capping protein 
lysine side-chains46 prior to tryptic digestion.  Next, selective derivatization of the N-
termini of the resulting tryptic peptides via attachment of a UV chromophore (AMCA) 
prior to LC-UVPD-MS generates predominantly y ion MS/MS spectra. Finally, the 
resulting spectra are processed by UVnovo, which combines a random forest classifier 
and a hidden Markov model (HMM) to thousands of peptides at high confidence from an 
E. coli cell lysate. 
4.3 EXPERIMENTAL 
4.3.1 Materials 
Mass spectrometry grade trypsin-gold was purchased from Promega (Madison, 
WI, USA).  LC-MS grade acetonitrile and water were purchased from EMD Millipore 
(Darmstadt, Germany). Phosphate buffered saline (PBS), dimethyl sulfoxide were 
purchased from Thermo Fisher Scientific Inc.  (San Jose, CA, USA)). 
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Sulfosuccinimydyl-7-amino-4-methyl-coumarin-3-acetic acid (AMCA) was purchased 
from Pierce Biotechnology (Rockford, IL, USA). E. coli lysate was graciously donated 
by Dr. M. Stephen Trent’s research group at the University of Texas at Austin. 
4.3.2 Modification of E.coli Lysate. 
A schematic showing the work flow for the modification of protein samples is 
shown in Figure 4.1a. For E. coli lysate, 50 μg of the lysate in 100 μL of 50 mM sodium 
carbonate and 8 M urea was heated at 80 °C for 4 hours (Figure 4.1b). This caused 
carbamylation of all lysine side chains (-amines) and N-termini primary amines in order 
to prevent subsequent reactions with AMCA at those amines. After carbamylation, 
proteins were buffered exchanged into PBS to remove urea. Proteins were digested using 
trypsin at 37 °C overnight.  After digestion, 25 µL of 20 mM AMCA in DMSO was 
added to the solution and kept in the dark overnight at room temperature. Following 
modification with AMCA samples were cleaned using a C18 SPE cartridge, evaporated 




Figure 4.1: a) Workflow for carbamylation/AMCA modification,  b) carbamylation 
reaction. 
4.3.3 LC-MS/MS analysis of E.coli lysate 
Peptides were separated and analyzed using a Dionex NSLC 3000 nanoLC system 
(Thermo Scientific; Waltham, MA, USA) interfaced to a Thermo Velos Pro dual linear 
ion trap  mass spectrometer (Thermo Scientific; San Jose, CA) modified to allow UVPD 
with a Coherent 351 nm excimer laser (Coherent; Santa Clara, CA, USA).47 The laser was 
set to 3 mJ per pulse at 500 Hz, with 15 pulses per scan. We used a 15 cm capillary 
column packed with 3.5 µm particles (C18 stationary phase) with a pore size of 140 Å, 
 82 
loading 5 µg of peptide mixture. Samples were eluted for analysis by UVPD using a 360 
minute gradient starting at 3% B and increasing to 50% B with a flow rate of 300 nL/min; 
solvent A was water with 0.1 % formic acid (v/v), and solvent B was acetonitrile with 
0.1% formic acid (v/v). For E. coli lysates the gradient was extended to 360 min to 
account for the increase in sample complexity. 
4.3.4 SEQUEST 
In order to obtain a list of high confidence peptide spectral matches, the raw 
spectra were analyzed using the SEQUEST and Percolator nodes of Proteome Discoverer 
v. 1.4 (ThermoFisher Scientific, San Jose, CA). AMCA was required as a fixed N-terminal 
modification, and optional oxidized methionine if any position was allowed. The 
precursor mass tolerance was set at ±1.6 Da due to the low resolution of ion trap 
spectra. SEQUEST was set up with standard settings except that lysine cleavage of 
trypsin was disabled by selecting Trypsin(R) in the settings. The reason lysine cleavage 
was disabled is because carbamylation of lysines prevents trypsin from cleaving at 
lysines. The search was set so that b-ions would not be considered and only y-ions 
would be searched for UVPD data sets. The database used was an E. coli reference 
database from UniProt. 
4.3.5 De novo analysis using UVnovo 
We implemented UVnovo, a de novo sequencing program for analysis of UVPD 
spectra, using the MATLAB programming language. Training and validation of UVnovo 
relied on spectra identified with high confidence through database searching. 
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4.3.5.1 Generation of high confidence data sets 
Raw E. coli UVPD spectra were analyzed using the SEQUEST and Percolator nodes 
of Proteome Discoverer v. 1.4 (ThermoFisher Scientific, San Jose, CA). AMCA was 
required as a fixed N-terminal modification, and optional oxidized methionine of any 
position was allowed. The precursor mass tolerance was set at ±1.6 Da due to the low 
resolution of ion trap spectra. SEQUEST was set up with standard settings except that 
lysine cleavage of trypsin was disabled by selecting Trypsin(R) in the settings. The 
reason lysine cleavage was disabled is because carbamylation of lysines prevents trypsin 
from cleaving at lysines. The search was set so that b-ions would not be considered and 
only y-ions would be searched for UVPD data sets. The database used was an E. coli 
reference database from UniProt. 
The top-ranked high confidence PSMs from charge 2+ precursor ions were used to train 
and benchmark UVnovo. Spectra were divided into independent training and test sets 
based on their respective peptide sequence, ignoring any PTM variants. 70% of identified 
peptides and all their associated spectra composed the training set, while the remaining 
30% of peptides with associated spectra were used for validation and de novo 
benchmarking. Thermo *.raw files were converted to the mzXML format using 
MSConvert with peak picking, and peaks with an intensity < 2 were removed.  
4.3.5.2 UVnovo 
Following data import and preprocessing, spectral interpretation through UVnovo follows 
four main step: 
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1. Deconvolute MS2 fragmentation peaks into predicted N-terminal peptide cleavage 
site locations using a random forest model. 
2. Refine the cleavage site predictions using a hidden Markov model. 
3. Identify amino acid sequences that best fit the predictions. 
4. Score the de novo sequence reconstructions. 
4.3.5.3 Deconvolution of fragmentation patters 
Similar to charge deconvolution, where a predictable series of distinct peaks can 
be mapped to single mass, fragmentation pattern deconvolution combines the evidence 
from multiple related peaks into prediction of a single base peak. For example, the 
presence of b, y, and y-H2O ion peaks is strongly indicative of a specific fragmentation 
site along a peptide’s backbone. And as with a series of charge or isotope peaks being 
resolved into a single 1+ charge peak, this coterie of fragment ions can be resolved into a 
single base peak. The process significantly cleans up a spectrum and improves 
interpretability. 
Long the domain of descriptive, count based statistical models, the interpretation of 
fragmentation ion patterns can likewise be approached from a machine learning 
perspective. We introduce here the application of random forest models to the 
computational interpretation and translation of MS/MS spectra into predictions of peptide 
fragmentation sites. 
 Random forest (RF) classifiers are an ensemble machine learning method that 
have been successfully applied across a wide range of fields. An ensemble, in machine 
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learning, aggregates many individual predictive models and usually combines their 
output into a single prediction. RF ensembles in particular construct a ‘forest’ of 
independent decision trees. These trees are a simple type of classifier often prone to 
overfitting, a problem that must be carefully guarded against in most statistical models. 
When combined into a RF or related ensemble, however, they turn into very powerful 
models. 
Each tree is fit on a random sample with replacement from a training data set, using a 
random sample of the predictors at each node in the tree. Enforcing randomness in the 
construction of the individual trees ensures that the trees are uncorrelated, and this 
reduces the problem of overfitting for the final random forest ensemble. To apply the RF 
to a set of input variables, each the trees in the ensemble generates a binary prediction. 
The random forest returns the average of these predictions as the probability of belonging 
to either of the two output classes. 
We used MATLAB’s implementation of random forests to created an ensemble of 
400 decision trees. Random forests take as input a vector of predictor variables and, 
during training, a binary class labels for each vector. The RF ensemble was trained 
primarily with peak values from MS
2
 spectra normalized in the following manner. 
Fragment m/z values were divided by a mass defect normalization constant, 1.000468, 
and rounded to the nearest integer. The constant was designed to minimize the residual 
fraction left over from rounding, following the same principle as used in Kendrick mass 
calculations. In the case of coincident peaks while rounding, the highest intensity peak 
was retained. Peak intensity values were replaced for the RF predictions by a normalized 
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rank score. For each spectrum, intensities were ranked from highest to lowest, and the 
rank was divided by the precursor mass. Local fluctuation in peak intensity was reduced 
by subtracting the minimum normalized rank within a sliding window. 
For a fragment mass M, with M defined as the sum of amino acid masses composing 
the N-terminal sequence, we created a predictor vector primarily consisting of MS/MS 
peak scores potentially related to the mass M. This included normalized rank scores for 
all peaks within -50 to +63 m/z of M or its complementary C-terminal position at Mparent-
M. Charge 2+ peaks were also included, adjusting the window locations and sizes 
accordingly. Additionally, 3 derived predictors were included in the predictor vector: 
M/Mparent, ceiling(M/100), ceiling((Mparent-M)/100). The final two are both rounded up 
(ceiling) and indicate which 100 Da bin the fragment ion falls in from the N and C-
termini. This gave a total of 347 predictor variables at each fragmentation site. 
From the training spectra described above, we created a set of positive and negative 
training examples for the RF modeling. The positive examples included a predictor 
vector for each true fragment mass M from all of the spectra. The negative examples 
were created similarly with a random shift applied to each of the original masses M. 
Random forests can return importance measures of input variables as a side effect of 
their training, and we used this to perform variable selection. RF models were 
constructed over four rounds, and we retained a smaller set of the most important 
predictors for each successive iteration. There were 30 variables remaining after three 
rounds of selection, and these were used to train the final RF model. 
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This model was then be applied to the unknown spectra of the test set at each integer 
mass position M where a bare fragment ion was possible. This generated a new 'spectrum' 
of peak mass versus probability for each original spectrum. Such probabilities generated 
by the random forest must be treated cautiously, since RF probability estimates tend 
toward the extreme, 0 and 1.  
4.3.5.4 Scoring of fragment sites 
We implement a hidden Markov model (HMM) to compute probabilities for all 
potential fragmentation sites at each position within a peptide. These fragmentation sites 
are the hidden states of the HMM, and they represent all possible amino acid sequences 
with mass equal to the precursor. Therefore, the path between two states in the HMM is 
equivalent to an amino acid mass. Starting from 0 Da, the HMM propagates belief along 
all possible paths using the forward-backward procedure, a relatively efficient dynamic 
programming algorithm. It only keeps track of the combined probability, or posterior, for 
each state it reaches, regardless of how many paths coincide at the state. 
This probability is primarily determined by the peak predictions from the RF, or 
observations. The state transition probabilities, moving from on fragment site to the next, 
depend in part on a first-order Markovian approximation of amino acid sequences. Our 
model includes the probabilities, in both the forward and backward directions, of 
observing a specific residue given the one that immediately preceded it. Additionally, the 
probability of transitioning between specific states is affected by the frequency prior of 
observing a specific amino acid at that position in the sequence. We have incorporated 
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into the HMM the expected frequencies of observing an amino acid at either of the N or 
C termini or as an interior residue. 
These probability matrices were constructed based on amino acid frequencies in an in 
silico digested E. coli reference proteome. However, they could in practice be based on 
any sequence database similar to the organism or sample under study. The probability of 
observing methionine was divided between its oxidized and unoxidized forms, at a rate 
matching that observed in a proteomically identified E. coli peptide data set. We plan to 
implement an expectation maximization method for the HMM to learn automatically the 
most likely rate of methionine oxidation or of any other PTM not yet included. Frequency 
and transition probabilities were marginalized against integer residue mass, meaning the 
residue pairs I/L, and F/Moxidation were indistinguishable. Lysine and glutamine could 
be distinguished thanks to the complete carbamylation of Lys. The probability of 
cysteines was set to 0 since peptides were not alkylated and disulfide bonding would 
make observation of cysteine-containing peptides exceedingly rare. 
The HMMs as described are each constructed to model a specific sequence 
length. As the length of a true peptide sequence is not known, HMM are constructed for 
the set of most likely candidate lengths of a particular spectrum. Generally, 1 to 5 models 
are created for each spectrum. The fragment site probabilities are different in each model 
since the set of sequences composing each are necessarily disjoint. 
4.3.5.5 Finding the best path 
The forward-backward algorithm and HMM construction described above can 
identify the most likely fragment mass states at each position along the sequence. These 
 89 
states only represent which masses likely correspond to a fragmentation site, and they 
may not all derive from the same peptide. There is often not a viable amino acid 
transition between all of the most probable states. 
We use the Viterbi algorithm on the HMM results to obtain the most likely amino 
acid sequence reconstruction. This moves through the fragmentation site HMM posterior 
probabilities and identifies the single most likely path through the set of nodes. 
Our algorithmic approach is currently limited in that we only find, for a given 
pectrum, the single best path from each selected AA sequence length. Extending this to 
the proveably correct set of top n paths becomes a more challenging problem. 
4.3.5.6 Scoring de novo reconstructions 
Sequence reconstructions were scored, ranked, and filtered to create a finished set of 
de novo sequences. The probability that a de novo reconstruction is correct is equivalent 
to the joint probability that all predicted nodes are correct and all true nodes were 
predicted. As the nodes are not independent, the true probability cannot be easily derived, 
and a simple upper bound is chosen according to the Fréchet inequality as the probability 
for the single lowest node in the sequence: 
P(sequence) ≤ P(n1 & n2 & … & nk) ≤ min(P(n1), P(n2), …, P(nk)) 
This score on its own can be used to rank candidate sequences. However, it is often 
biased in favor of the shorter of two similar sequences. Using the training set, we 
identified a better metric comprising a linear combination of the minimum HMM node 
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probability, the average node probability, and the log of the sequence length. Candidate 
sequences for each spectrum are ranked by this score metric. Additionally, a filter was 
established based on both the minimum and average node scores. Top ranked sequences 
that do not meet the threshold are removed along with all other sequences from the same 
spectra. 
4.4 RESULTS 
We based our strategy to increase the confidence of peptide identification on the 
ability to use UVPD for efficiently generating C-terminal fragment ion (y ion) series 
while eliminating N-terminal ions (a, b ions).  This strategy required an efficient means 
to attach a UV chromophore at peptides’ N-termini in order to target them by UVPD, 
while avoiding labeling of lysine side-chains that would result in indiscriminant 
chromophore attachment.  We describe an efficient sample processing scheme that 
accomplishes these goals and enables UVPD-based de novo peptide sequencing. 
4.4.1 Lysine capping with carbamylation 
In order to confine AMCA modification to the N-termini of peptides, the epsilon 
amino group on lysine side chains must first be blocked. Previously we used 
guanidination, which converts lysines into homoargines via reaction with O-
methylisourea in the presence of 7 N ammonium hydroxide.31,40  Trypsin digestion 
followed by reaction in the highly basic conditions required for guanidination 
necessitated several clean-up steps which resulted in loss of lower abundance peptides, 
thus tempering the success of the method for high throughput analysis of complex 
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digests. Lysine capping at the intact protein level was used to circumvent this 
shortcoming; trypsin digest would then proceed only at arginine residues. Carbamylation 
was evaluated as a quick and efficient alternative to guanidination for lysine capping.46 
Heating samples at 80 °C for four hours in an 8 M urea solution resulted in complete 
reaction of reactive primary amines on model proteins, including the N-termini and lysine 
side-chains.46 As a proof of concept, myoglobin was subjected to the carbamylation 
reaction, then the intact protein was directly analyzed (without proteolysis).  Myoglobin 
has nineteen lysine residues plus a free N-terminus (Figure 4.2a).  The resulting ESI 
mass spectrum showed a mass shift of 860.09 Da from the control (non-carbamylated) 
protein, which equates to the mass shift expected for the carbamylation of twenty amine 
reactive sites (see Figure 4.2b and c). The reaction efficiency was estimated to be nearly 
quantitative based on the ESI mass spectrum shown in Figure 4.2c. 
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Figure 4.2: a) Myoglobin has 20 possible carbamylation sites (highlighted in yellow). 
Comparison of (b) the ESI-mass spectrum of myoglobin with (c) the ESI-
mass spectrum of myoglobin after carbamylation in urea shows that the 
carbamylated myoglobin has a mass of 17,800.99 Da, corresponding to 
myoglobin with 20 sites of carbamylation and nearly 100% carbamylation 
efficiency at each Lys site. High accuracy ESI mass spectra were collected 
on an Orbitrap Elite. 
 
  4.4.2 Validation of UVnovo using E.coli lysate 
In order to measure performance on a complex protein sample, we applied the 
capping/AMCA strategy to a full E. coli lysate. The lysate was carbamylated, digested, 
and derivatized with AMCA, and analyzed via LC-MS/MS with UVPD. Figure 4.3 
displays a representative UVPD spectrum from an E.coli peptide from elongation factor 
 93 
G OS protein.  As anticipated, the spectrum displays a remarkably clean series of y ions. 
The b ions (which contain the N terminus) retain the AMCA chromophore and are  
 
Figure 4.3: UVPD (3 mJ per pulse, 15 pulses) mass spectrum of AMCA-tagged and 
lysine-carbamylated VYSGVVNSGDTVLNSVKAAR (2+) from a trypsin-
digested E. coli lysate. The precursor is labeled with an asterisk.  
 
susceptible to photoabsorption during consecutive laser pulses. Upon increasing the 
number of laser pulses used for ion activation, the b ions are annihilated from the UVPD 
spectrum, leaving only the y series as surviving ions. Very few internal fragment ions are 
observed.  Fragment ions are often absent C-terminal to proline, but otherwise y ion 
fragments created from backbone cleavage at all other positions are observed. The lack of 
complementary b and y ion pairs hampers the assignment of correct precursor mass. In all 
results below, the precursor mass was assigned to the integer nearest the PSM mass. 
However, the benefits of the UVPD method for de novo sequencing are twofold, and they 
cannot be overstated. First, with a complete y ion ladder, full length, gapless de novo 
reconstructions are commonly attainable for non-trivial peptides. Second, the spectra 
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display an ion ladder from only the C-terminus, dramatically reducing or eliminating the 
computationally intractable antisymmetric path problem (where mirror-image sequences 
propagate along both N-terminal and C-terminal ion ladders). De novo algorithms 
commonly address this problem by making imprecise assumptions, such as requiring that 
b and y ions not share the same integer mass. Such assumptions are unnecessary in this 
case.  
Spectra from triplicate E. coli runs were processed with Proteome Discoverer 
SEQUEST using the Percolator node and allowing a ±1.6 Da precursor mass tolerance. 
Limiting the results to doubly charged precursors and top-ranked matches, 7911 high 
confidence identifications matching 2983 unique peptide were obtained from a total of 
106,870 spectra collected across all three samples. These PSMs were divided into two 
independent sets, where 70% of identified peptides and all their associated spectra 
composed the training set. We used the remaining 30%, 2438 spectra, to test the UVnovo 
algorithm, thus avoiding spectrum or peptide-level biases introduced during model 
creation. 
As illustrated in Figure 4.4, the UVnovo spectral processing pipeline progresses 
through four main steps for each MS/MS spectrum, each detailed in the Materials and 
Methods. Briefly, the spectrum is first simplified using a Random Forest (RF) classifier. 
At each integer mass position along the spectrum, the RF merges evidence from 30 
predictors, selected and learned through training, to classify the site as either a C-terminal 
fragment ion or not. Next, a Hidden Markov Model is constructed from the RF spectrum 
and a first-order amino acid transition frequency table, and is used to estimate the 
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probability for each site to correspond to a true fragment ion. Using the Viterbi algorithm, 
the highest scoring sequence path through the network is identified. Each spectrum can 
then be assigned one or more potential sequences, with a single best sequence generated 
for each likely spectrum peptide length.  
 
Figure 4.4: UVPD (3 mJ per pulse, 15 pulses) mass spectrum of AMCA-tagged and 
lysine-carbamylated VYSGVVNSGDTVLNSVKAAR (2+) from a trypsin-
digested E. coli lysate. The precursor is labeled with an asterisk.  
 
Having arrived at one or more de novo sequences per spectrum, the fragment 
node probabilities, as determined from the HMM, are used to score the sequences. The 
probability that a de novo reconstruction is correct is equivalent to the joint probability 
that all predicted nodes are correct and all true nodes were predicted. As the nodes are not 
independent, the true probability cannot be easily derived, and a simple upper bound is 
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chosen according to the Fréchet inequality as the probability for the single lowest node in 
the sequence: 
P(sequence) ≤ P(n1 & n2 & … & nk) ≤ min(P(n1), P(n2), …, P(nk)) 
Candidate sequences can then be sorted in descending rank order by these scores.  
For the case of the E. coli lysate data set, UVnovo generated correct top-ranked 
sequences for 47.7% of the test spectra, and when considering the top three de novo 
sequences for each spectrum, 58.2% had an exact full-length match to the corresponding 
SEQUEST PSM (Figure 4.5a). The length distribution of correct reconstructions was 
biased toward smaller peptides, though even >45% of peptides at least 20 residues long 
had a completely correct de novo sequence within the top three predictions (Figure 4.5a). 
As expected, the average sequence assignment precision falls with falling scores (Figure 
4.5b). The de novo precision could be improved dramatically by exclusion of low ranked 
de novo reconstructions. This preferentially removed many of the false positive 
predictions while retaining 88.6% of true predictions, boosting the precision to 67.2% 
and 78.4% for top one and top three de novo sequence sets, respectively (Figure 4.5c and 
d). 
Such predictive accuracy—notably, seen here from relatively low-resolution mass 
spectra—broadly matches the performance of other de novo sequencing algorithms on 
high-resolution, higher-energy collisional dissociation (HCD) datasets. For example, a 
recent comparison of five de novo algorithms on optimized datasets showed comparable 
levels of accuracy.48 The results obtained from the E. coli digests from UVnovo appear 
on par with or out-perform these other methods considering only the correct identification 
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from the top de novo match. When expanded to the top five matches the UV novo results 
are again on par and are only slightly behind three of the programs which boast 
approximately 80% correct identifications when using HCD data. A direct comparison of 
these algorithms on the same datasets is unfortunately not currently feasible, given the 
differences in fragmentation applicability. 
 
Figure 4.5: UVnovo de novo results for the E. coli lysate test set. No sequence gaps are 
allowed for a correct match. a) shows the number of true peptide 
identifications (defined as agreement with high confidence SEQUEST 
peptide spectral matches) by UVnovo as a function of peptide length, 
plotting results for the top de novo result and the top three de novo results of 
the same length. b) plots the percentage of total correct matches across all 
sequence lengths, as a function of rank, demonstrating effective ranking of 
hits by UVnovo. c, d) Filtering to remove low rank de novo reconstructions 
further improves relative performance. 
While UVnovo boasts competitive results for full-length reconstructions, another 
metric is the extent of error present in incorrect sequences. Figure 4.6 displays the 
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frequency and extent of amino acid sequencing errors versus peptide length. Of the 
misidentified sequences, half (52.0%) differ from the SEQUEST PSM by only two amino 
acids, suggesting that only one fragmentation site per peptide is predicted incorrectly. 
This, along with the high rate of full sequence recovery, demonstrates the benefit of 
complete fragmentation along entire peptides. 
 
Figure 4.6: Heat map plotting relative frequency and extent of amino acid identification 
errors versus peptide lengths for the E. coli lysate test sample. Most de novo 
reconstructions are correctly reconstructed with no insertions or deletions; 
incorrectly identified gaps tend to be short, predominantly 2 amino acids. 
We occasionally observed co-eluting peptides in our data manifesting as 
differences between the de novo sequence and SEQUEST PSM for a spectrum. In some 
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cases, this resulted in a hybrid de novo sequence blended from the two precursor 
peptides. Ideally, however, the differing de novo results complement the SEQUEST 
identification, and both are correct. Figure 4.7 presents such an example, where coeluting 
peptides AKLLQYAER and VIELTKKAM
Oxy[+16]
 both contribute to the observed 
spectrum and are identified through SEQUEST and de novo, respectively. The 
assignments are supported by independent identification of each from alternative, less 
overlapping spectra. Interestingly, the lone spectrum with a SEQUEST PSM of 
VIELTKKAM was partitioned into the test set, and all five AKLLQYAER spectra were 
part of the training set, including the spectrum in Figure 4.7. That this spectrum, partly 
composed of ions used during training, was ascribed to an unfamiliar peptide implies the 
UVnovo models were not significantly biased or overtrained. Additionally, this and 
similar observations indicate that other disagreeing de novo sequences may not 






Figure 4.7: Example UVPD MS/MS spectrum in which UVnovo conflicts with 
SEQUEST. SEQUEST matches this spectrum to peptide 
VIELTKKAM
Oxy[+16]
 , whereas UVnovo identifies this spectrum as deriving 
from peptide AKLLQYAFR. The presence of a complete y-ion series for 
each peptide suggests the spectrum results from co-eluting peptides. 
 
4.5 CONCLUSIONS 
We describe a new experimental method and supporting algorithm, UVnovo, for 
de novo peptide sequencing by UVPD. The high efficiency of carbamylation for capping 
lysine side-chains at the protein level, subsequent tryptic digestion, then selective 
derivatization of the N-termini of the resulting peptides with a UV chromophore 
(AMCA) results in UVPD mass spectra that contain predominantly y ions and that are 
well suited for de novo sequencing. UVnovo combines a random forest classifier and a 
Hidden Markov model to simplify and interpret UVPD fragmentation spectra, enabling 
the de novo sequencing of thousands of peptides from an E. coli lysate at high 
confidence. In comparing de novo results to a reference set derived by database matching, 
UVnovo identified 47.7% of the sequences correctly when only the top result was 
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considered and 58.2% when the top three results are considered. These results are 
improved to 67.2% for the top result and 78.4% for the top three results when reasonable 
filters were applied to the data. When incorrect, the de novo results generally agreed with 
the true sequence within two incorrect amino acids. Further refinement of the UVnovo 
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Incorporation of UVPD/CID paired spectra Analysis and De Novo 
Sequence Tag /Database look-up to Expand the Capabilities of UVnovo 
5.1 OVERVIEW 
UVnovo capabilities are expanded to allow UVPD/CID paired spectra to be 
searched. E.coli lysate peptides modified with a UV chromophore and analyzed by 
ultraviolet photodissoication (UVPD) and collision induced dissociation (CID) on the 
same precursors to generate paired UVPD/CID spectra. Top ranked de novo 
reconstructions correctly identified 68.3% of searched spectra (compared to 62.9% for 
UVPD and 35.3% for CID alone) and 79.1% when the top three scored sequences from 
UVnovo were considered (51.9% for CID and 75.9% for UVPD alone). These results 
improved to 78.2% (75.9% for UVPD and 51.9% for CID alone) for the top result and 
88.1% (86.7% for UVPD and 71.3% for CID alone) for the top three results when a filter 
was applied. The paired UVPD/CID datasets integrated with the UVnovo algorithm 
capitalized on the benefits of both spectra types while ignoring or canceling out the 
negative effects of CID and/or UVPD spectra alone (redundant ions, precursor mass 
assignment).  UVnovo was also modified to allow performance of sequence tag de novo 
sequencing which can be used to identify matching sequences from a database. UVnovo 
identified 2,260 unique peptides compared to 1,689 identified with PEAKS and 1,957 
identified with SEQUEST for an E. coli lysate. Andrew Horton, a doctoral student in the 
Marcotte group is credited with the development, optimization, testing, and modifications 




The ability of Identify proteins in complex mixtures is a challenging task in the 
field of proteomics. While advancements in mass spectrometry (MS) have led to great 
improvement in number and confidence in the proteins identified based on analysis of 
proteolytic peptides, the vast amount of data generated from high throughput LCMS runs 
makes  manual searches for peptide hits impractical. As a result much effort has been 
directed towards the development of peptide sequencing algorithms. There are two main 
types of programs:  in silico database search methods and de novo sequencing. In silico 
search programs match experimental MS/MS spectra of peptides to predicted tandem 
mass spectra generated from a protein database and have been tremendously successful in 
the field of cellular proteomics.
1–6
 De novo sequencing algorithms, on the other hand, 
directly interpret peptide sequences from the masses and mass differences of fragment 
ions observed in tandem mass spectra and thus do not require the use of a protein 
database. The use of the latter programs have been shown to be effective for the 
identification of truncated proteins, post-translational modifications (PTMs), and 
sequence mutations, all of which pose problems for in silico programs.
7
 The most popular 











One of the main factors that improve the success of de novo programs is the 
creation of MS/MS spectra which contain few missed peptide backbone cleaves and are 
devoid of any type of neutral losses such as loss of water, ammonia, or amino acid side 
change. Spectra that meet these conditions are ideal for de novo sequencing as the 
algorithms can derive fragment ion identities (i.e. amino acid compositions) while 
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limiting incorrect assignments as a result of spectrum being cluttered with redundant or 
uninformative ions, ones that confound de novo sequencing. In an effort to create these 
optimal mass spectra, a variety of methods have been developed based on chemical 
derivatization to manipulate the fragmentation patterns of peptides. Keough et al. made 
one of the first major contributions by using a negatively charged sulfonic acid group to 
modify the N-termini of peptides, thus resulting in the neutralization of N-terminal 
product ions while leaving only the C-terminal ions as detectable charged fragment 
ions.
13,14
 This strategy proved to be an effective means to simplify the MS/MS spectra of 
peptides. Over the years other groups have improved upon or used similar ideas to 
modulate MS/MS spectra to improve de novo sequencing.
15–26
 Some of the more recent 
approaches integrated Lys-N proteolysis with dimethyl isotope labeling to easily 
distinguish N-terminal ions from C-terminal ions
27
 or derivatized the C-terminus of 
peptides using a phosphonium reagent to facilitate production of b-type ions.
28,29
 
For the majority of bottom-up proteomics workflows, collisional induced 
dissociation (CID) is the dominant ion activation method, resulting in b and y fragment 
ions.
30,31
 Other activation techniques have been developed as a means to provide greater 
sequence coverage and/or enhance the retention of PTM information, such as electron 
capture dissociation (ECD)
30





 The use of ETD spectra for peptide sequencing has become 
so common that PEAKS has incorporated a de novo algorithm created by Liu et al. 
adapted for ETD spectra.
36
 ETD has likewise been combined with some of the 
derivatization methods described above to further extend the feasibility of ETD for de 
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novo strategies.  For example,  our group reported appending a 4-sulfophenyl 
isothiocyante (SPTIC) modification to the N-termini of peptides to generate de novo 
friendly spectra containing mainly z-type ions.
37
 More recently Richards et al. showed 
that ETD spectra of neutron-encoded stable isotope labeled peptides yielded 
•
z- type 
doublets ions that were well-suited for de novo interpretation.
38
 PD, specifically 
ultraviolet PD (UVPD), has also been shown to be an effective method to generate 
fragments for de novo sequencing.
39–44
 Zhang and Reilly first reported that 157 nm 
UVPD produced rich fragmentation patterns of peptides that could be used for de novo 
sequencing.
39,40
 193 nm UVPD coupled with Lys-N proteolysis was shown by our group 
to yield triplet series of N-terminal ions (a,b,c) ideal for sequencing of unknown 
peptides.
41
 We also showed that 355 nm UVPD combined with N-terminal derivatization 
of peptides resulted in the elimination of b-ions from tandem mass spectra resulting in a 
clean series of y-ions.
42
 Further adaptation of this method for 351 nm UVPD proved to be 
very effective for de novo sequence of tryptic digest of proteins in which the peptides 
were tagged at the N-terminus with sulfosuccinimydyl-7-amino-4methyl-coumarin-3-
acetic (AMCA).
43
 Most recently, we have modified an E.coli lysate via carbamylation 
and AMCA derivatization in order to create and validate a new program to effectively 
perform de novo sequencing on 351 nm UVPD data called UVnovo.
45
 
Recently de novo methods have begun to incorporate a practice of utilizing 
multiple activation methods for peptide analysis so that paired spectra could be 
searched.
46-48
 With ETD, ECD and CID being both widely available and at the same time 
often offering complementary information, it is not surprising that a majority of methods 
 114 
that used paired data have focused on these activation methods. One of the first to do so 
was Savitski et al. who showed that using CID/ECD spectral pairs significantly improved 
identification of peptides via de novo sequencing.
44
 A de novo sequencing program called 
Spectrum Fusion was developed by Datta and Bern which used the CID/ETD data and a 
Bayesian Network to create single combined spectra from the paired data.
46
 An et al. 
demonstrated that paired CID/ETD spectra and on-tip derivatization of peptides by 




Described herein we have adapted our recently developed de novo sequencing 
method, UVnovo, to search CID/UVPD paired spectra, resulting in improved 
identification of peptides compared to that of CID or UVPD alone. In addition UVnovo 
has been modified to allow sequence tag de novo searches. Sequence tags searching is 
performed by de novo sequencing of only a small section of the peptide (typically 3 to 5 
residues); these results are then searched against a database in a type of hybrid de novo/in 
silico search method. Using this method to search MS/MS data from E.coli lysate, the 




Mass spectrometry grade trypsin-gold was purchased from Promega (Madison, 
WI, USA).  LC-MS grade acetonitrile and water were purchased from EMD Millipore 
(Darmstadt, Germany). Phosphate buffered saline (PBS), dimethyl sulfoxide were 
 115 
purchased from Thermo Fisher Scientific Inc.  (San Jose, CA, USA)). 
Sulfosuccinimydyl-7-amino-4-methyl-coumarin-3-acetic acid (AMCA) was purchased 
from Pierce Biotechnology (Rockford, IL, USA). E.coli lysate was graciously donated by 
Dr. M. Stephen Trent research group at the University of Texas at Austin. 
5.3.2 Modification E.coli lysate 
Modification of E.coli lysate was performed as described previously.
45
 In short 
E.coli lysate was carbamylated to block the reactive primary amines of the lysine side-
chains by mixing 50 μg of the lysate in 50 mM sodium carbonate with 8 M urea and 
heating for 4 hours at 80 °C.  The resulting carbamylated proteins were then buffer 
exchanged into PBS to remove urea and subsequently digested using trypsin at 37 °C 
overnight. After digestion, 25 µL of 20 mM AMCA in DMSO was added to the solution 
and kept in the dark overnight at room temperature. Following the AMCA modification a 
C18 SPE cartridge was used to clean the samples by removal of residual AMCA. Finally 
the samples were dried and reconstituted in an appropriate LC solvent. 
5.3.3 LC-MS/MS analysis of E.coli lysate 
Peptides were analyzed using a Dionex NSLC 3000 nanoLC system (Thermo 
Scientific; Waltham, MA, USA) interfaced to a Thermo Velos Pro dual linear ion trap  
mass spectrometer (Thermo Scientific; San Jose, CA) that was previously modified for 
UVPD via a Coherent 351 nm excimer laser (Coherent; Santa Clara, CA, USA).
48
 The 
laser was set to 3 mJ per pulse at 500 Hz, and 15 pulses were used for all experiments.  
Due to the complexity of the E.coli lysates, a 360 min gradient was used from 3% B 
increasing to 50% B with a flow rate of 300 nL/min. Mobile phase A was water with 0.1 
% formic acid (v/v), and mobile phase B was acetonitrile with 0.1% formic acid (v/v)).  
Approximately 5 ug of peptide mixture was loaded on the column.  The in-house packed 
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column was a 15 cm capillary packed with 3.5 µm particles (C18 stationary phase) with a 
pore size of 140 Å. Collision induced dissociation (NCE 35, 10 ms) and UVPD (15 
pulses at 3 mJ per pulse) were undertaken for each sample. For the collection of paired 
CID/UVPD data, ion trap control language (ITCL) was customized to allow enhanced 
selectivity of activation parameters within the dual-pressure ion trap during LCMS 
analysis.  Briefly, setting the NCE value to 0 for CID specified that isolated precursor 
ions were transferred to the low-pressure cell (LPC) followed by laser pulse triggering to 
obtain optimal UVPD results.  In contrast, if the NCE parameter was set to a value above 
0, the isolated precursor ions were retained in the high-pressure cell (HPC) for optimal 
CID fragmentation efficiency while laser pulse triggering would be inactive.  After CID, 
fragment ions were transferred from the HPC to the LPC for subsequent detection. 
5.3.4 PEAKS analysis 
PEAKS 6 (Bioinformatics Solution Inc.; Waterloo, ON, Canada) was used as a 
comparison sequence tag search algorithm. Raw files were converted into mzXML and 
then imported into the PEAKS database. Standard ion trap search parameters were used 
for both de novo and database comparisons. The AMCA modification was added to the 
PTM section of the database as a fixed modification at the N-terminus.  After completion 
of the PEAKS processing, the results were then checked against the Uniprot E.coli 
database. 
5.3.5 SEQUEST analysis 
In order to obtain a list of true peptides from the E.coli lysate, SEQUEST run 
through Proteome Discoverer v. 1.4 (ThermoFisher Scientific, San Jose, CA) was used. 
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AMCA was added as a fixed modification on the N-terminus of all peptides. SEQUEST 
was set up with standard settings except that lysine cleavage of trypsin was disabled by 
selecting Trypsin(R) in the settings. The database used was an E. coli reference database 
from UniProt.  
5.3.6 UVnovo Modifications 
A detailed description of UVnovo workflow has been described previously.
45
 
However new modification to the program were performed as follows  
5.3.6.1 Merging UVPD/CID paired spectra 
Processing and analysis of the paired CID/UVPD spectra proceeded in the same 
manner as described for the UVPD sample. The main difference, merging of spectral 
pairs into a single fragmentation probability spectrum, was accomplished by simply 
concatenating the predictor vectors into a single input for the random forest training and 
application. Again, the RF model was trained four times, with variable selection 
shrinking the number of predictors each iteration. The original set of 691 combined 
predictors from the UVPD and CID spectra was reduced to the set of the 33 most 
important variables, as determined automatically by the RF model. These were used to 
train a final RF model that could be immediately applied to paired CID/UVPD spectral 
data. All subsequent processing was identical to the previously described UVPD methods 
for generating and scoring de novo sequence reconstructions. 
5.3.6.2 Hybrid sequence tag database search 
We digest in silico the forward and shuffled E. coli protein coding sequences to 
enable a target/decoy search strategy. We additionally create a hash table mapping all 
kmers, for 3≤k≤6, back to the the peptides they compose. This allows fast searching of de 
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novo sequence tags against the database for tags of length k. For each spectrum with a de 
novo sequence reconstruction, any database peptides with matching tags and a mass 
within ±2 Da of the precursor are scored against the sequence and HMM node scores. 
Oxidized methionine is allowed as an optional modification for this search. 
We applied an optimization algorithm to a set of 4 derived peptide match features 
and trained a discriminative scoring function to maximize the number of target peptides 
identified at a 1% FDR. 
5.4 RESULTS 
5.4.1 UVnovo incorporation of paired spectra 
E.coli lysate was digested and modified as described above. The carbamylation 
reaction blocked all primary amines at the protein level. Trypsin, inhibited from acting on 
the blocked lysines, cleaved C-terminal to arginine, generating peptides with new 
primary amines solely at the N-terminus. The subsequent AMCA reaction installed a UV 
chromophore at the N-terminus of each peptide, making the peptides well-suited for 351 
nm UVPD. 
ESI-MS/MS was performed using a dual cell linear ion trap mass spectrometer 
equipped with a 351 nm laser.
49
 Following each MS1 survey scan, UVPD/CID spectra 
pairs were acquired for each of five selected precursors. The generation of UVPD/CID 
spectra required a modification of the instrument control software as CID is typically 
performed in the high pressure trap to ensure optimal dissociation and UVPD results are 
more optimal when carried out in the low pressure trap. Modification of the instrument 
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control software, as described in the experimental section, allowed seamless switching 
between UVPD and CID in alternating scans.   The MS/MS spectra generated by UVPD 
for the AMCA-modified peptides exhibited series of y ions. Complementary b ions were 
annihilated during the multi-pulse UVPD period due to the high photoabsorptivity of the 
AMCA-tagged N-termini of the b ions;  y ions did not contain a UV chromophore and 
survived as stable ions in the ion trap. The MS/MS spectra produced upon CID of the 
same AMCA-tagged peptides displayed conventional b and y ions with the b ions 
retaining the AMCA modification. Figure 5.1 shows a set of paired UVPD/CID spectra 
for a peptide from Probable transcriptional regulatory protein YebC OS from the digested 
E.coli lysate. 
 
Figure 5.1: Example of MS/MS spectra observed for a single peptide when obtained via 
alternating CID and UVPD modes. The peptide shown is AMCA-tagged 
ELVTAAK(carbamyl)LGGGDPDANPR (2+) from an E. coli lysate digest. 
The precursor is labeled with an asterisk. a) CID (NCE 35) from scan 
18750, and  b) UVPD (3 mJ per pulse, 15 pulses) from scan 18751.  
 120 
 
Spectra from an E. coli UVPD/CID paired run were processed using Proteome 
Discoverer SEQUEST with the Percolator node and allowing a ±1.8 Da precursor mass 
tolerance. Optional methioinine oxidation was included in addition to fixed N-terminal 
AMCA and carbamylated lysine modifications. Limiting the results to doubly charged 
precursors and top-ranked matches, 4,854 high confidence identifications matching 1957 
unique peptides were obtained from a total of 51,525 spectral pairs (103,050 spectra) 
collected across all three replicates.  
We processed the UVPD/CID spectral pair with our de novo analysis program, 
UVnovo, and benchmarked its performance against that obtained using only the CID or 
UVPD subset of scans from the same data set. Spectra, individual or paired, were 
transformed using a random forest classifier into a single vector of scores for each 
potential C-terminal fragmentation position. This output, along with empirically derived 
amino acid frequency statistics, was further refined into a series of fragmentation site 
probabilities using a hidden Markov model (HMM). Application of the Viterbi algorithm 
then found the most probable de novo sequences, and these were scored based on the 
individual and aggregate fragment probabilities determined by the HMM. 
The paired UVPD/CID spectra were processed with UVnovo. The UVnovo 
results are displayed in Figure 5.2 as the number of correct sequences binned according 
to peptide length and shown in comparison to the peptide spectral matches found by 
Sequest. The unfiltered data for the paired spectra returned  68.3% correct matches for 
top scored de novo sequences and 79.1% when the set was expanded to the top three 
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scored de novo matches for each spectrum (Figure 5.2a and b). As with the CID and 
UVPD data, low ranked de novo reconstructions were able to be removed which 
increased the results for the top ranked de novo match to 78.2% and the results for the top 
three ranked set to 88.1% (Figure 5.2c and d). In addition to the paired spectra both the  
 
Figure 5.2: UVnovo de novo results for paired UVPD/CID spectra from E.coli lysate. No 
sequence gaps are allowed for a correct match. a) Graphical display of the 
number of peptides correctly identified (from SEQUEST results)  grouped  
by peptide length in comparison to the number of correct matches based on 
the top de novo result and the number of correct matches based on the top 
three de novo results. b) Graphical display of  the percentage of correct 
matches when considering all peptide lengths. The line shows the 
cumulative total upon addition of all correct matches from peptide 
sequences with a lower de novo rank. c) and d) Graphical displays showing 
the  UVnovo results after the application of a filter to remove all low rank de 
novo reconstructions.  
UVPD and CID spectra were processed using UVnovo separately in order to compare 
these to the paired spectra results. For UVPD, The top-ranked sequences generated were 
correct 62.9% and when considering the top three sequences constructed by UVnovo 
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73.9% of the returned sequences corresponded to an exact full length match to the 
SEQUEST PSM (Figure 5.3a and b). The application of a filter to remove low ranked de 
novo reconstructions resulted in an increase in the overall accuracy of the UVnovo results 
for both the top one and top three sets which were improved to 75.9% and 86.7%, 
respectively (Figure 5.3c and d). CID spectra were then searched using UVnovo which 
resulted in correct top ranked sequences for only 35.3% of the spectra; this value 
increased to 49.0% when considering the top three highest scored de novo sequences for 
each spectrum (Figure 5.4a and b). The CID results were also filtered in the same way 
as the UVPD, resulting in an increase in the results to 51.9% and 71.3% for the top one 








Figure 5.3: UVnovo de novo results for UVPD spectra from E.coli lysate. No sequence 
gaps are allowed for a correct match. a) Graphical display of the number of 
peptides correctly identified (from SEQUEST results) grouped by peptide 
length in comparison to the correct number of matches based on the top de 
novo result and the number of correct matches based on the top three de 
novo results. b) Graphical display of the percentage of correct matches when 
considering all sequence lengths. The line shows the cumulative total upon 
addition of correct matches from peptide sequences with a lower de novo 
rank. C) and d) Grapical displays showing the UVnovo results after the 
application of a filter to remove all low rank de novo reconstructions.  
 
The relatively poor performance of CID is a direct result of the spectra containing 
both b and y type ions. The complementary nature of b and y type ions often results in 
mirror image ion ladders along the back bone from both N- and C-terminus. While 
redundant fragmentation can be useful if a cleavage site is in one the of the ion ladders to 
help fill in the gaps, it is also detrimental as it increases the difficulty of constructing a 
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sequence because the algorithm must distinguish between b- and y- fragments. As a result 
of this shortcoming the standalone UVPD outperforms CID due to the fact that b ions are 
eliminated from the MS/MS spectra.  
 
Figure 5.4: UVnovo de novo results for CID spectra from E.coli lysate. No sequence gaps 
are allowed for a correct match. a) Graphical display of the number of 
peptides correctly identified (from SEQUEST results) grouped by peptide 
length in comparison to the correct number of matches based on the top de 
novo result and the number of correct matches based on the top three de 
novo results. b) Graphical display of the percentage of correct matches when 
considering all sequence lengths. The line shows the cumulative total upon 
addition of correct matches from peptide sequences with a lower de novo 
rank. C) and d) Graphical displays showing the UVnovo results after the 
application of a filter to remove all low rank de novo reconstructions.  
 
The combination of CID and UVPD spectra result in a noticeable improvement in 
the number of correct de novo reconstructions observed compared to either CID or 
UVPD alone. The paired UVPD/CID datasets capitalize on the benefits of both types of 
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spectra while ignoring or canceling out the drawbacks of either CID or UVPD spectra. As 
noted above, the redundant b/y ion ladders from CID impairs reconstruction of the correct 
sequences. UVPD does not suffer from this problem and allows more accurate de novo 
sequence reconstruction; however, the assignment of the precursor mass is more 
challenging from the UVPD spectra because complementary mirror image sequences 
provide more confidence with this task (a notable advantage of the CID spectra). Thus, 
combining the UVPD and CID spectra results in even more accurate results from 
UVnovo. 
5.4.2 Sequence Tag Analysis 
An additional modification of UVnovo allowed usage as a de novo tag based 
hybrid search algorithm. UVnovo was altered to facilitate incomplete sequence 
reconstructions, known as sequence tags. These tags are searched against a known 
database to generate candidate peptide sequences, which are then scored and ranked. The 
E.coli lysate data files were searched using UVnovo modified to perform sequence tag de 
novo sequencing and was searched against a Uniprot E.coli database with a shuffled 
decoy. Using this method, UVnovo matched 2,260 peptides identified from the E.coli 
lysate. UVnovo outperformed PEAKS, a de novo program that also uses sequence tag 
assignments, which identified 1,689 peptides from the same dataset.  The enhanced 
performance of the custom algorithm was attributed to the absence of b ions in the 
spectra which normally complicate ion assignments in de novo workflows. The 
performance of UVnovo was also compared to SEQUEST, a traditional in silico database 
search program, which returned 1,957 peptide hits. As demonstrated for the E coli lysate, 
the reduction of spectral complexity obtained by AMCA-tagging and selective UVPD 
proved to be a strategic advantage for de novo sequencing. 
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5.5 CONCLUSIONS 
Two unique modifications to the de novo program, UVnovo, have been 
implemented to capitalize on paired UVPD/CID spectra of AMCA-modified E.coli lysate 
tryptic peptides. UVnovo was used to search paired UVPD/CID spectra and compared to 
the analysis of UVPD or CID spectra separately. The UVPD/CID paired spectra out-
performed both UVPD and CID as top ranked de novo reconstructions were correct for 
68.3% of searched spectra (compared to 62.9% for UVPD alone and 35.3% for CID 
alone) and  79.1% when the top three scored sequences from UVnovo are considered 
(75.9% for UVPD alone and 51.9% for CID alone). These results are improved to 78.2% 
(compared to 75.9% for UVPD alone and 51.9% for CID alone) for the top result and 
88.1% (86.7% for UVPD alone and 71.3% for CID alone) for the top three results when a 
filter is applied to remove low ranked de novo results. These results convey the 
successful use of UVnovo for  increasing the confidence in the de novo sequencing of 
peptides using a paired CID/UVPD approach. Secondly UVnovo was altered to allow the 
generation of de novo sequence tags. These sequence tags were then searched against a 
database which resulted in the identification of 2,260 unique peptides from the E.coli 
lysate. Comparing this to another hybrid de novo/database search program (PEAKS) and 
a traditional in silico program (SEQUEST), UVnovo returned a larger number of unique 
peptides than either PEAKS (1689 peptides) or SEQUEST (1957 peptides). The 
UVnovo/paired UVPD/CID strategy improved the confidence of searches and enabled 
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Comparison of Ultraviolet Photodissociation and Collision Induced 
Dissociation of Adrenocorticotropic Hormone Peptides  
6.1 OVERVIEW 
In an effort to better characterize the fragmentation pathways promoted by 
ultraviolet photoexcitation in comparison to collision induced dissociation (CID), six 
adrenocorticotropic hormone (ACTH) peptides in a range of charge states were subjected 
to 266 nm ultraviolet photodissociation (UVPD), 193 nm UVPD, and CID.  Similar 
fragment ions and distributions were observed for 266 nm UVPD and 193 nm UVPD for 
all peptides investigated. While both UVPD and CID led to preferential cleavage of the 
Y-S bond for all ACTH peptides (except ACTH (1-39)), UVPD was far less dependent 
on charge state and location of basic sites for the production of C-terminal and N-
terminal ions. For ACTH (1-16), ACTH (1-17), ACTH (1-24) and ACTH (1-39), changes 
in the distributions of fragment ion types (a,b,c, x, y, z and collectively N-terminal ions 
versus C-terminal ions) showed only minor changes upon UVPD for all charge states.  In 
contrast, CID displayed significant changes in the fragment ion type distributions as a 
function of charge state, an outcome consistent with the dependence on the number and 
location of mobile protons that is not prominent for UVPD.  Sequence coverages 
obtained by UVPD showed less dependence on charge state than those determined by 
CID, with the latter showing a consistent decrease in coverage as charge state increased.   
  
6.2 INTRODUCTION 
Significant advances in mass spectrometry for proteomics applications have 
evolved from the development of increasingly powerful informatics methods as well as 
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new ion activation techniques and more sophisticated MS/MS strategies to improve the 
characterization of peptides in complex mixtures. The latter include deployment of real-
time decision tree methods
1,2
, use of targeted ion monitoring methods
3–5
, development of 
hybrid ion activation methods
6–8
, and strategic ion manipulation based on ion-ion 
reactions
9,10
 and innovative ion charging concepts
11,12
.  There has also been growing 
effort to understand and optimize the fragmentation pathways of peptides to improve 
sensitivity, to enhance recognition of peptides in database searches, and in some cases to 
exploit preferential bond cleavages to provide greater specificity
13–15
. While collision- 
and electron-based methods remain the most universally popular activation methods
16–21
, 





energy cation beam activation
26
, metastable atom activation
27
) have been developed to 
afford higher energy deposition and expand the arsenal of ways to energize ions to create 
meaningful fragmentation patterns. 
Photon-based activation methods (termed photodissociation) offer considerable 
versatility, and this has led to a number of applications for analysis of peptides and 





 and  visible photodissociation (Vis-
PD).
25,60–62
  The most common wavelengths used for UVPD of peptides include 157 nm, 
193 nm, 266 nm, 351 nm and 355 nm, each corresponding to ones readily generated by 
pulsed excimer or YAG lasers.  The photodissociation process requires that the peptides 
of interest possess a suitable chromophore, either via an intrinsic chromophore (e.g., 
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amide bond or side-chains groups of amino acids) or ones added via derivatization of the 
peptides prior to analysis.
63–65
  For example, peptides do not naturally absorb photons 
around 350 nm, but they can be tagged with appropriate chromophores to make them 
undergo photodissociation, ultimately producing conventional b/y-type fragment ions.
43-45
  
This strategy has been reported  for the identification of antigen binding regions of 
antibodies
44
, for streamlining bottom-up proteomics
45
, and has also shown to useful in de 
novo sequencing by simplifying spectra.
43
 The amide bond absorbs 157 and 193 nm 
photons, thus serving as the chromophore for 157 nm and 193 nm UVPD of peptides and 
proteins.  The high energy per photon (7.9 eV for 157 nm and 6.4 eV for 193 nm) can 
elevate ions to excited electronic states, thus accounting for the production of a wide 
array of a, b, c, x, y, and z ions. Both 193 nm and 157 nm UVPD have been reported for 
numerous bottom-up proteomic applications and more recently for top down 
characterization of intact proteins.
36,37
 A detailed investigation of 157 nm UVPD 
demonstrated that some of the fragmentation pathways were radical directed.
38
 Also a 
recent study has shown that high energy fragmentation methods where electrons excited 




In contrast to 193 nm and 157 nm photons, 266 nm photons are not absorbed by 
the peptide backbone but rather by the amino acid side chains of tyrosine, tryptophan and 
phenylalanine.  Despite the lower energy per photon (4.6 eV), 266 nm UVPD also results 
in cleavages that lead to formation of a,b,c,x,y and z ions, similar to the types of ions 
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formed upon absorption of 157 nm or 193 nm photons.
25
 Oh et al. reported the rich array 
of fragment ions upon 266 nm UVPD of protonated peptides and noted enhanced 
backbone cleavages adjacent to aromatic amino acids (tryptophan, phenylalanine and 
tyrosine).
47
 The Kim group also showed that tryptic peptides derivatized by phenyl 
isothiocyanate reagents required lower laser powers for efficient photodissociation at 266 
nm, thus confirming the enhanced photoabsorption cross-sections attributed to the added 
aromatic chromophores.
49
 Kim and coworkers also analyzed phosphopeptides using 266 
nm UVPD which led to the production of highly characteristic an – 97 ions affiliated with 
each phosphorylated residue.
57
  Park et al. used 266 nm UVPD to analyze phosphorylated 
peptides in an FTICR mass spectrometer, finding a consistent loss of 98 Da.
50
 The Julian 
group has shown that absorption of 266 nm photons promotes selective homolytic 
cleavage of disulfide and C-S bonds, thus providing a means to map cysteine residues in 
peptides and proteins.
51
 Ly and  Julian also utilized 266 nm photons to activate peptides 
or proteins containing iodinated tyrosines, leading to a process termed radical directed 
dissociation (RDD)  which results in site-localized fragmentation and can be used as a 
spatially-specific probe of protein structure in the gas phase.
53,54,56
 In another RDD 
strategy, Diedrich and Julian showed that phosphorylated sites in peptides could be 
pinpointed using a Michael addition reaction with naphthalenethiol followed by 266 nm 
UVPD to selectively cleave the C-S bond installed during the Michael addition 
reaction.
56
 More recently  Tao et al. showed that D- and L- amino acids in peptides could 




This variety of photon-based activation methods has propelled interest in 
understanding the correlation between the photon wavelength and the outcomes of 
peptide activation in terms of dissociation efficiency, the types of fragmentation 
processes, and the potential for selective bond cleavages.  Detailed comparisons of the 
fragmentation pathways and distributions of fragment ions arising from 157 nm, 193 nm, 
and 266 nm UVPD have not been extensively explored.  Recently Lai et al. compared the 
fragmentation caused by 193 nm UVPD and 266 nm UVPD for singly protonated 
peptides, including angiotensin (DRVYIHPF) analogues and bradykinin 
(RPPGYSPFR).
66
 They noted numerous similarities in the types of fragment ions (both 
ones derived from amide and non-amide backbone cleavages and some side-chain 
cleavages) produced by 193 nm and 266 nm UVPD along with some variations in relative 
abundances.
66
  Herein we report the UVPD patterns of six adrenocorticotropic hormone 
(ACTH) peptides as a function of charge state and amino acid composition. ACTH 
peptides were chosen as they contain the three amino acids with aromatic side-chains 
(Phe, Trp, Tyr) that serve as the optimal chromophores for absorption of 266 nm photons 
(as well as secondary chromophores for 193 nm photons).  Our goal is to extend the 
fundamental understanding of 266 nm UVPD in comparison to 193 nm UVPD and 




The six ACTH (human) peptides, ACTH (1-10, sequence SYSMEHFRWG, Mr 
1298.4), ACTH (1-14, sequence SYSMEHFRWGKPVG, Mr 1679.9), ACTH (1-16, 
sequence SYSMEHFRWGKPVGKK, Mr 1936.3), ACTH (1-17, sequence 
SYSMEHFRWGKPVGKKR, Mr 2092.4), ACTH (1-24, sequence 
SYSMEHFRWGKPVGKKRRPVKVYP, Mr 2932.5), ACTH (1-39, sequence 
SYSMEHFRWGKPVGKKRRPVKVYPNGAEDESAEAFPLEF, Mr 4540.1), as well as 
Alpha-Bag Cell peptide (1-9 sequence APRLRFYSL Mr 1122.3), [Tyr5] Bradykinin 
(sequence RPPGYSPFR Mr 1076.2), [Phe2, Nle4] ACTH (1-24  sequence 
SFS(Nle)EHFRWGKPVGKKRRPVKVYP, Mr 2899.5), and Adamtsostatin-16 (sequence 
SPWSQCATSCGGGVQTR with a disulfide between the two cysteiens Mr 1722.9) were 
purchased from American Peptide Company (Sunnyvale, CA, USA). LC-MS grade 
acetonitrile and water were obtained from EMD Millipore (Darmstadt, Germany). LC-
MS grade formic acid was purchased from Fisher scientific (Fair Lawn, NJ). 
6.3.2 Mass Spectrometry 
All experiments were carried out using a Thermo Velos Pro dual linear ion trap 
mass spectrometer (Thermo Scientific; San Jose, CA) or a Thermo Orbitrap Elite mass 
spectrometer (Thermo Scientific; Bremen, Germany).  The dual linear ion trap was used 
for the MS/MS comparisons based on 266 nm UVPD, 193 nm UVPD, or CID, and the 
orbitrap instrument was used primarily to confirm specific fragment ion assignments 
based on high resolution, high accuracy measurements. The dual linear ion trap was 
modified to allow UVPD with a Continuum Minilite Nd:YAG laser (Santa Clara, CA, 
USA) set to 266 nm or a Coherent Excistar excimer laser (Santa Clara, CA) set to 193 
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nm. The set-up and implementation of UVPD was similar to that described previously.
31
 
Peptides were diluted in a 50/50 acetonitrile/water solution with 0.1% formic acid to a 
final concentration of 1 µM and were infused at a flow rate of 3 µL/min. CID was 
performed on every observed charged state of each of the six ACTH peptides using a 
normalized collision energy of 35%. 266 nm UVPD was performed on each charge state 
observed for the six ACTH peptides using 1, 2, 5, or 10 pulses (nominally 6 mJ per pulse) 
at a 10 Hz laser pulse rate. 193 nm UVPD was also performed for all observed charge 
states of the six ACTH peptides using 2 pulses and 2 mJ per pulse at 500 Hz laser pulse 
rate. Only a fraction of the light enters the ion trap due to the fact that neither focusing 
nor collimating optics are used, and the laser beam is divergent as it emerges from the 
laser.  Due to the relatively low photon flux through the ion trap, the extent of secondary 
(or consecutive) fragment ion dissociation is minimal.   
6.3.3 Analysis of Spectra 
All CID and UVPD spectra were analyzed manually. Lists of fragments were 
obtained using both Protein Prospector v. 5.12.2 (UCSF) and Proteomics Tool kit 
(Institute for Systems Biology). Data for the fragment ion distributions was processed 
using Microsoft Excel. Abundance information was extracted from the raw data and used 
to calculate the percentage distributions for each type (b and y for CID and a, b, c, x, y, 
and z for UVPD). 
6.4 RESULTS 
6.4.1 266nm UVPD, 193 nm UPVD, and CID of ACTH peptides 
UVPD using 266 nm photons has been less frequently employed for analysis of 
peptides than 193 nm UVPD, and it seemed particularly important to evaluate the 
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fragmentation induced by 266 nm photon absorption as well as the similarities and 
differences to that caused by 193 nm photon absorption.  In order to investigate the 
variations in peptide fragmentation obtained by 266 nm UVPD, each charge state of the 
six ACTH peptides was activated using one to ten laser pulses.  MS/MS spectra were also 
acquired by conventional CID and by 193 nm UVPD (2 pulses) to compare the types and 
distribution of fragment ions obtained by each of the three activation methods.  Examples 
of the MS/MS spectra produced by 266 nm UVPD (5 laser pulses), 193 nm UVPD, and 
CID are shown in Figure 6.1 for ACTH (1-17) (3+ charge state).
 
Figure 6.1: MS/MS spectra of 266 nm UVPD, 193 nm UVPD, and CID fragmentation of 
the ACTH (1-17). Precursor Ion is in the 3+ charge state labeled with an 
asterisk. . a) 266 nm UVPD (5 pulses 6 mJ per pulse), b) 193 nm UVPD (2 
pulses; 2 mJ per pulse), and c) CID (NCE 35%). 
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Both the 266 nm UVPD and 193 nm UVPD spectra show a rich array of fragment ions, 
ranging from the conventional a/b/y ions observed upon CID to c/z ions typically 
observed upon electron-activated (radical type) dissociation and x ions that are only 
commonly seen upon UVPD. The fragment ions in the visually congested UVPD spectra 
can be confidently assigned based on high accuracy measurements.  Figure 6.2 shows an 
expansion of the region from m/z 760 to 890 for peptide ACTH (1-24) (4+).  
 
Figure 6.2: Expanded region of the UVPD mass spectrum from m/z 760 to 890 for ACTH 
(1-24) 4+ spectra showing the rich fragmentation observed upon UVPD. 
The spectrum was collected on a high mass accuracy Thermo Orbitrap Elite 




UVPD (both 266 nm and 193 nm) and CID mass spectra for the other ACTH peptides are 
shown in Figures 6.3-7.  
 
Supplemental Figure 6.3: Examples of 266 nm UVPD, 193 nm UVPD, and CID mass 
spectra of ACTH (1-10). Precursor ion is in the 2+ charge state. a) 266 nm 
UVPD (5 pulses; 6 mJ per pulse), b) 193 nm UVPD (2 pulses; 2 mJ per 
pulse), and c) CID (NCE 35%). 
 
Histograms summarizing the distribution of fragment ions obtained by 266 nm UVPD, 
193 nm UVPD, and CID are shown in Figure 6.8 for ACTH (1-17) for each of its five 
charge states (2+, 3+, 4+, 5+, 6+), and additional histograms for all of the MS/MS data 
for each activation method are shown in Figures 6.9 (266 nm UVPD), 6.10 (193 nm 
UVPD) and 6.11 (CID).  The most prominent fragment ions produced by each activation 
method for each charge state of each peptide are summarized in Table 6.1.  
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Figure 6.4: Examples of 266 nm UVPD, 193 nm UVPD, and CID mass spectra of ACTH 
(1-14). Precursor ion is in the 3+ charge state. a) 266 nm UVPD (5 pulses, 6 
mJ per pulse), b) 193 nm UVPD (2 pulses; 2 mJ per pulse), and c) CID 
(NCE 35%). 
 
As expected, the number of laser pulses influenced the total abundance of 
fragment ions  produced upon 266 nm UVPD as well as the distribution of fragment ions 
to a lesser extent. Figure 6.12 shows the increase in the total fragment abundance for 
each charge state observed for the ACTH peptides as the number of laser pulses 
increases.  The total abundances of fragment ions generally increased with the number of 
pulses, a result expected because the precursor ion population was not annihilated using a 
single laser pulse and thus more precursor ions were converted to fragment ions upon 
each subsequent pulse.  The number of laser pulses used for 266 nm UVPD had a 
relatively minor influence on the distribution of fragment ions as  
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Figure 6.5: Examples of 266 nm UVPD, 193 nm UVPD, and CID mass spectra of ACTH 
(1-16). Precursor ion is in the 3+ charge state. a) 266 nm UVPD (5 pulses 6 
mJ per pulse), b) 193 nm UVPD (2 pulses; 2 mJ per pulse), and c) CID 
(NCE 35%). 
 
exemplified by the spectra shown in Figure 6.13 for ACTH (1-17) and summarized in 
bar graph format in Figure 6.14 for the highest and lowest charge states of each peptide.  
For the bar graph format, the abundances of a, b, c, x, y, and  z fragment ions were 
summed collectively based on ion type as a function of the number of laser pulses. 
Based on the graphical distributions shown in Figures 6.12 and 6.14 and the 
representative series of spectra in Figure 6.13, it is clear that the number of laser pulses 
has a relatively modest impact on the overall distribution of fragment ions for our UVPD 
set-up.  Visual comparison of the spectra in Figure 6.13  
 147 
 
Figure 6.6: Examples of 266 nm UVPD, 193 nm UVPD, and CID mass spectra of ACTH 
(1-24). Precursor ion is in the 4+ charge state. a) 266 nm UVPD (5 pulses, 6 
mJ per pulse), b) 193 nm UVPD (2 pulses; 2 mJ per pulse), and c) CID 
(NCE 35%).  
 
confirms that no new abundant ions are produced with an increasing number of laser 
pulses, suggesting that the majority of fragment ions are produced directly from the 
precursor ion, not via secondary dissociation of primary fragment ions.  (This outcome 
depends on the laser power and the overlap of the laser beam with the ion cloud, so it 
would be expected to be instrument-dependent). For all spectral comparisons discussed in 
the next section, 5 laser pulses were used for the 266 nm UVPD spectra and 2 laser pulses 
were used for the 193 nm UVPD spectra. 
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Figure 6.7: Examples of 266 nm UVPD, 193 nm UVPD, and CID mass spectra of ACTH 
(1-39). Precursor ion is in the 6+ charge state. a) 266 nm UVPD (5 pulses, 6 
mJ per pulse), b) 193 nm UVPD (2 pulses; 2 mJ per pulse), and c) CID 
(NCE 35%).  
 
6.4.2 Fragmentation Trends Observed in ACTH peptides 
The MS/MS spectra shown for ACTH (1-17) in Figure 6.1 and the stacked 
histograms in Figure 6.8 highlight some of the characteristic features observed for each 
activation method.   The distributions of N-terminal (a,b,c) versus C-terminal ions (x,y,z) 
ions produced by 266 nm UVPD versus 193 nm UVPD are remarkably similar for each 
ACTH peptide in every charge state.   For example, for the longer peptides (e.g. ACTH 
(1-24) and ACTH (1-39)),  the portion of C-terminal ions formed upon 266 nm UVPD or 
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193 nm UVPD remains around 50-55%, regardless of charge state, and the histogram 
 
Figure 6.8: Distribution of 266 nm UVPD, 193 nm UVPD, and CID fragment ions for all 
observed charge states of ACTH (1-17). 5 pulses at 6 mJ was used for 266 
nm UVPD, 2 pulses at 2 mJ was used for 193 nm UVPD, and 35% NCE 
was used for CID  
 
graphs in Figure 6.9 (for 266 nm UVPD) and Figure 6.10 (for 193 nm UVPD) mirror 
each other for each peptide.  The distribution of C-terminal versus N-terminal ions 
changes more dramatically for the shorter ACTH peptides (such as ACTH (1-10) and 
ACTH (1-14)), for which the portion of C-terminal product ions consistently increases 
from approximately 30% for the singly-charged peptides to upwards of 75% for the 3+ 
charge state.  An increase in the portion of C-terminal ions with increasing charge state is  
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Figure 6.9: Distribution of 266 nm UVPD fragment ions for all observed charge states of 
a) ACTH (1-10), b) ACTH (1-14), c) ACTH (1-16), d) ACTH (1-17), e) 
ACTH (1-24), and f) ACTH (1-39). UVPD was carried out using 5 pulses at 
6 mJ per pulse. 
 
similarly observed for ACTH (1-10), ACTH (1-14), ACTH (1-16) and ACTH (1-17) for 
both UVPD methods.  This increase in the portion of C-terminal (x,y,z) ions with 
increasing charge state is likely attributed to the predominance of basic sites on the 
second half of the peptide sequence, thus increasing the probability of charge retention 
for the C-terminal ions, but this effect does not necessarily reflect charge-modulated 
fragmentation directed by mobile protons as anticipated for CID. For the larger ACTH  
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Table 6.1: Comparison of Most Abundant Fragment Ions for ACTH Peptides1  
 
peptides, fluctuations in the distribution of N-termini versus C-termini ions upon UVPD 
are less notable, with variations of less than 10% for most of the ion types (a,b,c,x,y,z).  
 The distributions of fragment ions produced by CID are shown in the stacked 
histograms of Figure 6.11. The CID results are much more dependent on the initial 
charge state of the precursor peptide, with swings as much as 50% for C-terminal versus 
N-terminal ion types (e.g. 32% C-terminal ions for doubly-protonated ACTH (1-14) 
versus 82% C-terminal ions for triply-protonated ACTH (1-14)) and distributions that 
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seesaw dramatically depending on the precursor charge state (e.g. 65% C-terminal ions 
for singly  
 
Figure 6.10: Distribution of 193 nm UVPD fragment ions for all observed charge states 
of a) ACTH (1-10), b) ACTH (1-14), c) ACTH (1-16), d) ACTH (1-17), e) 
ACTH (1-24), and f) ACTH (1-39). 193 nm UVPD was carried out using 2 
pulses at 2 mJ per pulse. 
 
protonated ACTH (1-14), 32% C-terminal ions for doubly-protonated ACTH (1-14), and 
82% C-terminal ions for triply-protonated ACTH (1-14)). The shifts and seesaws in the 
C-/N-terminal fragment ion distributions for the CID data as a function of precursor 
charge state are not surprising.  CID pathways are known to be highly charge-mediated 
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with the number of mobile protons (i.e. ones not sequestered at highly basic sites) 
dictating the preferred fragmentation processes.
67
  The lack of significant variation in the  
 
Figure 6.11: Distribution of CID fragment ions for all observed charge states of a) ACTH 
(1-10), b) ACTH (1-14), c) ACTH (1-16), d) ACTH (1-17), e) ACTH (1-
24), and f) ACTH (1-39). CID was carried out using NCE of 35%. 
 
C-terminal/N-terminal fragment ion distributions for either 266 nm UVPD or 193 nm 
UVPD reflects the reduced impact of proton-mediated pathways and the greater 
contribution from dissociation processes that may occur directly from excited states 
and/or radical-modulated ones.  In addition, the rich diversity of UVPD fragment ions, as 
evidenced by the multi-segmented bars in Figures 6.8 to 6.10, underscores the wide 
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variety of competing (and possibly consecutive) pathways that minimize substantial 
variations as a function of charge state.  
 
Figure 6.12: Total intensity of fragment ions generated by 266 nm UVPD for all charge 
states using 1, 2, 5, or 10 pulses for a) ACTH (1-10), b) ACTH (1-14), c) 
ACTH (1-16), d) ACTH (1-17), e) ACTH (1-24), and f) ACTH (1-39). The 
total abundances of fragment ions generally increased with the number of 
pulses, a result expected because the precursor ion population was not 
annihilated using a single laser pulse and thus more precursor ions were 
converted to fragment ions upon each subsequent pulse.   
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The MS/MS spectra for the ACTH peptides are frequently dominated by several 
highly abundant fragment ions which are indicative of preferential cleavages.  The most  
 
Figure 6.13: 266 nm UVPD mass spectra of ACTH (1-17), 3+ charge state, activated 
using a varying number of laser pulses. a) 1 pulse, b) 2 pulses, c) 5 pulses, 
and d) 10 pulses at 6 mJ per pulse. The number of laser pulses used for 266 
nm UVPD had a relatively minor influence on the distribution of fragment 
ions. 
predominant fragment ions produced by UVPD and CID are compiled in Table 6.1 for 
each charge state of each ACTH peptide. For ACTH (1-10), several of the most dominant 
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fragment ions, namely a2, y4, y5,  and y8, are observed for all three activation methods, 
with cleavage of the backbone at the Y-S site leading to y8 and a2 ions  being particularly  
 
Figure 6.14: Distribution of 266 nm UVPD fragment ions for lowest and highest 
observed charge states of a) ACTH (1-10), b) ACTH (1-14), c) ACTH (1-
16), d) ACTH (1-17), e) ACTH (1-24), and f) ACTH (1-39). The highest 
and lowest charge states were selected to show the shift to C-terminal ions 
as the charge state of the precursor increases. UVPD was carried out using 5 
pulses at 6 mJ per pulse. The abundances of a, b, c, x, y, and  z fragment 
ions were summed collectively based on ion type as a function of the 
number of laser pulses. 
 
enhanced.  The UVPD spectra exhibit special enhancement of a ions that are not favored 
in the CID spectra, and these may arise from secondary dissociation of b ions formed 
with excess internal energy or ones produced directly from the precursor peptide, 
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potentially via dissociation of ions in excited electronic states.  The similarities between 
the 266 nm UVPD and 193 nm UVPD spectra (Figures 6.1, 6.9 and 6.10), both in terms 
of the identities and distributions of fragment ions, is remarkable.  The level of 
similarities even extends to the formation of a few low abundance z-type fragment ions 
which are absent from the corresponding CID mass spectra.  Apparently absorption of 
266 nm (4.7 eV) or 193 nm (6.4 eV) photons allows access to excited states (whether the 
same ones or different ones for each of these wavelengths), and the activation process 
leads to similar fragmentation processes.  Absorption of 193 nm photons may occur at the 
amide backbone as well as the aromatic side-chains of W, Y and F (the sites where 266 
nm photons are absorbed), with W having a greater photoabsorption cross section than Y 
or F.
48
 Based on previous studies of UVPD, it is believed that dissociation may occur 
directly from excited electronic states as well as after internal conversion and 
intramolecular vibrational redistribution.
39,68
Based on the present results that show a 
mixture of CID-like fragment ions (b/y) and radical-directed fragment ions (a/x, c/z), it 
appears that UVPD involves more than one type of process.   
The UVPD and CID spectra collected for ACTH (1-14) showed an even more 
dramatic preferential cleavage of the Y-S bond, leading to the dominant y12
2+
 ion for the 
3+ and 4+ charge states (and complementary a2 and b2 ions). The lower charge states (1+, 
2+) instead exhibited enhanced b11 and b13 ions upon 266 nm UVPD and CID, with the 
former representing a proline-type cleavage that also accounts for the prominent 
complementary y3 ion.  Interestingly, despite the overlap in the sequences of ACTH (1-
10) and ACTH (1-14), the resulting MS/MS spectra had few similarities, an outcome that 
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is largely attributed to the C-terminal ion dominance in the spectra that masks the more 
subtle variations in the N-terminal ion abundances.   
For ACTH (1-16), the Y-S cleavage (formation of y14) remained the most 
consistently prominent process upon UVPD and CID for the higher charge states (3+, 4+, 
and 5+) (see Figure 6.5).  Cleavage of the backbone between K-K (resulting in b15) was 
also a significant pathway, which is a hallmark charge-modulated process common for 
both UVPD and CID.   Selected a, c, and z ions were observed in the UVPD (266 nm and 
193 nm) spectra which again reflected the greater diversity of pathways upon UV 
photoactivation.   
ACTH (1-17) is an interesting example, having just a single additional arginine 
residue at the C-terminus compared to ACTH (1-16).  The resulting UVPD mass spectra 
(Figure 6.1) exhibited many of the same preferential cleavage sites as observed for 
ACTH (1-16), such as the enhanced Y-S cleavage and cleavage adjacent to a basic 
residue.  Similar to ACTH (1-16), the ACTH (1-17) ions in lower charge states (2+ and 
3+) underwent a dominant cleavage of the last amino acid in the sequence (K-R bond) 
resulting in the formation the b16 ion. UVPD of ACTH (1-17) also show prominent 
formation of the y15 ions which corresponded to the Y-S cleavage for 3+, 4+, 5+, and 6+ 
charge states, as well as a modest increase in C-terminal ions as the charge state 
increased.   
Four charge states (3+, 4+, 5+, and 6+) were observed for ACTH (1-24), and 
representative fragmentation patterns generated by UVPD and CID are shown in Figure 
6.6.  The relative portion of N-terminal ions compared to C-terminal ions produced by 
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UVPD was greater for all charge states compared to the distributions observed for the 
shorter ACTH peptides.   Again the Y-S bond cleavage was particularly favored, yielding 
the y22 (and a2) ions noted previously.   The a22 ion, arising from a V-Y backbone 
cleavage, was a significant product ion upon UVPD, and it has been observed previously 
that cleavages C-terminal to valine and N-terminal to tyrosine may be enhanced.
66
    
As the largest peptide in the series, ACTH (1-39) generated five charge states (3+, 
4+, 5+,6+ and 7+) upon ESI and some rather unique results for both 266 nm UVPD and 
CID (Figure 6.7). This peptide sequence is unusual in that there are no basic sites found 
within the final 18 residues (C-terminus).  For 266 nm UVPD the cleavage of the S-Y 
bond was not observed for any charge state; in fact there was no consistent preferential 
cleavage for any of the charge states upon UVPD. CID resulted in the dominant 
formation of a b35 ion which arises from cleavage of the F-P bond, a process consistent 
with the well-known rule of peptide cleavage N-terminal to proline.  N-terminal b ions 
were highly favored upon CID of all charge states, presumably because the most basic 
charge sites which were clustered closer to the C-terminus for the shorter peptides, are 
actually situated in the mid-region of ACTH (1-39).  This means that cleavages at 
backbone sites in the mid-section of the peptide more likely result in fragment ions with 
protons localized in the first 21 residues, thus enhancing N-terminal ions (such as the 
dominant b29, b33, b35, b38 ions, among others, noted in Table 6.1).  Interestingly, the 
distribution of N-terminal versus C-terminal ions for ACTH (1-39) is almost evenly split 
(50%/50%) upon 266 nm UVPD and 193 nm UVPD.  In contrast, N-terminal fragments 
make up 70-75% of the fragment ions upon CID.   The C-terminal ions that are observed 
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are long ones that contain basic residues from the N-terminal half of the peptide.  The 
notable differences in C-terminal versus N-terminal fragment ion distribution further 
supports the lower degree of charge-site dependence on the fragmentation pathways 
observed upon UVPD.  
 
Figure 6.15: Examples of 266 nm UVPD, 193 nm UVPD, and CID mass spectra of 
Alpha-Bag Cell Peptide. Precursor ion is in the 2+ charge state. a) 266 nm 
UVPD (5 pulses; 6 mJ per pulse), b) 193 nm UVPD (2 pulses; 2 mJ per 
pulse), and c) CID (NCE 35%). 
 
In an effort to elucidate the reason for the apparent preferential cleavage of the Y-
S bond observed upon activation of the ACTH peptides, four additional peptides were 




Figure 6.16: Examples of 266 nm UVPD, 193 nm UVPD, and CID mass spectra of 
Bradykinin [Tyr 5]. Precursor ion is in the 3+ charge state. a) 266 nm UVPD 
(5 pulses; 6 mJ per pulse), b) 193 nm UVPD (2 pulses; 2 mJ per pulse), and 
c) CID (NCE 35%). 
due to its position in the peptide (the second and third residues), a special lability of the 
Y-S bond,  or a chromophore effect (although it is noted that this bond cleavage is also 
observed upon CID, not just UVPD).   Bradykinin [Tyr5] and alpha- bag cell peptide (1-
9) were chosen because they both have a Y-S bond near the C-terminus (alpha-bag cell 
peptide (1-9) or the middle ( bradykinin [Tyr5] of the peptide rather than near the N-
terminus. For the alpha-bag cell peptide (1-9) fragments resulting from a cleavage of the 
Y-S bond appear as some of the more abundant fragments observed (Figure 6.15). The 
cleavage of the Y-S bond was fairly prominent for bradykinin[Tyr 5] and was only 
surpassed by proline cleavages (Figure 6.16), giving evidence that the preferential Y-S  
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Figure 6.17: Examples of 266 nm UVPD, 193 nm UVPD, and CID mass spectra of 
ACTH (1-24) [Phe 2, Nle 4]. Precursor ion is in the 4+ charge state. a) 266 
nm UVPD (5 pulses; 6 mJ per pulse), b) 193 nm UVPD (2 pulses; 2 mJ per 
pulse), and c) CID (NCE 35%). 
 
cleavage observed for the ACTH peptide is not solely due to location of the Y-S residues 
near the N-terminus . Another peptide selected was ACTH (1-24) [Phe 2 Nle 4] for which 
the Tyr in ACTH at position 2 is replaced by Phe. The fragments observed from both 
UVPD and CID for this peptide are nearly identical to those seen for the original version 
of the ACTH (1-24) peptide, with the y22 and a2 ions produced in great abundance 
(Figure 6.17). The fact that cleavage between the F-S residues parallels the preferential 
cleavage observed for the Y-S residues suggests that the preferential cleavage may arise 
from an aromatic residue/Ser motif.  The third peptide analyzed was adamtsostatin-16 
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which contained a W and S residues at the third and fourth positions, respectively. The 
resulting UVPD and CID mass spectra are shown in Figure 6.18. In this case,  cleavage 
of the W-S bond is not overly favored.  In total, it appears that a new preferential 
cleavage associated with X-S in which X is Y or F occurs upon UVPD or CID, a feature 
that might be prevalent in larger scale bottom-up proteomic studies. 
 
 
Figure 6.18: Examples of 266 nm UVPD, 193 nm UVPD, and CID mass spectra of 
Adamtsostatin-16. Precursor ion is in the 2+ charge state. a) 266 nm UVPD 
(5 pulses; 6 mJ per pulse), b) 193 nm UVPD (2 pulses; 2 mJ per pulse), and 




6.4.3 Comparison of 266 nm, 193 nm, CID sequence coverage for ACTH peptides  
 
 
Figure 6.19: Sequence coverage maps for observed ions in all observed charge states of 
ACTH (1-10). Any backbone cleavage site producing N-terminal a, b, c ions 
is represented by ┐. Any backbone cleavage producing C-terminal x,y, z 
ions is represented by └. Cleavages that result in both N-terminal a, b, c ions 
and C-terminal x, y, z ions are designated by      .  
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Among the series of ACTH peptides, the UVPD spectra of the smaller peptides 
were more “CID-like” in terms of the portion of a,b, and y ions, particularly for ACTH 
(1-10) (3+) and ACTH (1-14) (4+).   For the longer ACTH peptides and/or ones in lower  
 
Figure 6.20: Sequence coverage maps for observed ions in all observed charge states of 
ACTH (1-14). Any backbone cleavage site producing N-terminal a, b, c ions 
is represented by ┐. Any backbone cleavage producing C-terminal x,y, z 
ions is represented by └. Cleavages that result in both N-terminal a, b, c ions 
and C-terminal x, y, z ions are designated by  
 
charge states, the UVPD spectra exhibited the greater diversity of fragment ions that is 
the established hallmark of UV photoactivation. In terms of sequence coverages (i.e. 
expressed as a percentage based on the number of backbone cleavages relative to the total 
number of backbone positions), UVPD and CID typically gave similar coverages for the 




Figure 6.21: Sequence coverage maps for observed ions in all observed charge states of 
ACTH (1-16). Any backbone cleavage site producing N-terminal a, b, c ions 
is represented by ┐. Any backbone cleavage producing C-terminal x,y, z 
ions is represented by └. Cleavages that result in both N-terminal a, b, c ions 
and C-terminal x, y, z ions are designated by        .  
However, for higher charge states, UVPD generally yielded higher coverages 
compared to CID, especially for 193 nm UVPD.  For example, the 2+ charge state of 
ACTH (1-16) yielded a sequence coverage of 87% (13 backbone cleavage sites out of 15 
sites) for both CID and 266 nm UVPD. However, for the 5+ charge state the sequence 
coverage decreased to only 33% for CID and 47% for 266 nm UVPD. The sequence 
coverage obtained upon 193 nm UVPD showed less variation, ranging from 67% to 
100% across the four charge states.  For ACTH (1-17), Figure 6.21 shows a sequence 
coverage map for all five charges states for 193 nm, 266 nm, and CID fragmentation. 
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Figure 6.22: Sequence coverage maps for observed ions in all observed charge states of 
ACTH (1-16). Any backbone cleavage site producing N-terminal a, b, c ions 
is represented by ┐. Any backbone cleavage producing C-terminal x,y, z 
ions is represented by └. Cleavages that result in both N-terminal a, b, c ions 
and C-terminal x, y, z ions are designated by        .  
 
 A maximum of 75% coverage was obtained by CID and 266 nm UVPD for the lowest 
2+ charge state, whereas the coverage decreased to 38% for CID and 56% for 266 nm 
UVPD of the highest 6+ charge state.  The sequence coverage produced by 193 nm 
UVPD was again less charge-state dependent, ranging from 75% to 88% for ACTH (1-
17).  As anticipated, the level of coverage varied more dramatically for CID as a function 
of charge state compared to UVPD.  For instance, the sequence coverage ranged from 
70% (3+) to 26% (6+) for CID of the ACTH (1-24) peptide, whereas the range varied 
from 65% (3+) to 52% (6+) for 266 nm UVPD and from 74% (3+) to 61% (6+) for 193  
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Figure 6.23: Sequence coverage maps for observed ions in all observed charge states of 
ACTH (1-24). Any backbone cleavage site producing N-terminal a, b, c ions 
is represented by ┐. Any backbone cleavage producing C-terminal x,y, z 
ions is represented by └. Cleavages that result in both N-terminal a, b, c ions 
and C-terminal x, y, z ions are designated by      .  
 
nm UVPD of the same peptide.  The variation in sequence coverage was most notable for 
the longer ACTH peptides, those that contained basic lysine or arginine residues at the C-
terminus or in the middle of the sequences.  The change in sequence coverage obtained 
by CID for the longer peptides as a function of charge state was not surprising given the 
fact that CID is more highly modulated by proton mobility than UVPD. 
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Figure 6.24: Sequence coverage maps for observed ions in all observed charge states of 
ACTH (1-39). Any backbone cleavage site producing N-terminal a, b, c ions 
is represented by ┐. Any backbone cleavage producing C-terminal x,y, z 
ions is represented by └. Cleavages that result in both N-terminal a, b, c ions 
and C-terminal x, y, z ions are designated by       .  
 
6.5 CONCLUSIONS 
266 nm UVPD and 193 nm UVPD generated similar fragment ion distributions 
for each ACTH peptide, spanning a variety of a,b,c and x,y,z ions.  Comparison of the 
MS/MS results for ACTH (1-10), ACTH (1-14), ACTH (1-16), ACTH (1-17), and ACTH 
(1-24) revealed that UVPD and CID consistently showed preferential cleavage of the Y-S 
bond for nearly every charge state. For all of the peptides, the production of C-terminal 
versus N-terminal ions and overall sequence coverage was far more dependent on the 
charge state and location of basic sites for CID than for UVPD, an outcome that reflects 
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the reduced prominence of charge-mediated pathways  for UVPD.  In general, UVPD of 
the longer peptides (ACTH (1-16), ACTH (1-17), ACTH (1-24) and ACTH (1-39)) 
showed relatively little change in the distributions of fragment ion types as a function of 
the charge state of the peptide; there were much greater changes observed for CID.  
UVPD demonstrated a modest degree of preferential cleavage adjacent to amino acids 
containing aromatic side-chains, suggestive of a chromophore effect, as well as enhanced 
cleavages adjacent to proline akin to the well-known proline effect documented for CID.  
This systematic comparative study has demonstrated many similarities in the types and 
distributions of fragment ions produced by 266 nm UVPD and 193 nm UVPD, with 
greater overall sequence coverage afforded by 193 nm UVPD. A comparison of the 
results for 193 nm and 266 nm UVPD shows that shows that both provide better 
sequence coverage compared to CID for higher charge states of larger peptides.  193 nm 
UVPD provides better coverage on average than 266 nm UVPD, and the sequence 
coverages obtained by UVPD did not exhibit the significant dependence on charge state 
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The use of database search tools to evaluate mass spectrometry results has 
contributed to tremendous advancements in the understanding of the complex field of 
proteomics. In spite of all of the discoveries there is still a great deal about proteomics 
that remains unknown as it is almost impossible to predict the exact modifications or 
mutations that proteins may undergo. In an effort to better characterize and pinpoint the 
alterations protein experience, de novo sequencing programs are implemented which 
allow elucidation of protein information without any prior knowledge of the sample. The 
focus of this dissertation is the development of novel de novo methods which use peptide 
derivatization as well as ultraviolet photodissociation (UVPD) to create simplified spectra 
and subsequently employ those spectra to use a de novo program which capitalizes on the 
simplification of these spectra to yield superior de novo results. 
In Chapter 3, tryptic peptides were derivatized with sulfosuccinimydyl-7-amino-
4-methyl-coumarin-3-acetic acid (AMCA), a UV chromophore, and then activated using 
351 nm UVPD. Fragmentation with 351 nm UVPD caused the elimination of b-ions so 
that only y-ions remained as the lone series of ions observed. The simplified spectra were 
shown to be perfectly suited for de novo sequencing. The implementation of technique 
was shown to be effective in the analysis of single proteins, protein mixtures, as well as 
the differentiation of several different green fluorescent protein (GFP) variants. 
The improvement of the AMCA/351 nm method was discussed in Chapter 4. 
Refinements to the experimental workflow allowed this de novo technique to be applied 
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to complex cell lysates, creating simplified spectra from the AMCA/351 nm UVPD 
strategy. Using these spectra from the cell lysate a novel de novo sequencing program 
created by Andrew Horton that processed spectra using a Random Forest model and then 
generated potential peptide sequences for the spectra using a hidden Markov model 
(HMM) was tested. This new method was able to identify thousands of peptides from an 
E.coli lysate with high confidence and yielded results comparable or superior to that of 
other de novo algorithms. 
Further modifications were made to the new de novo program in Chapter 5. Paired 
UVPD/CID datasets in conjunction with the de novo algorithm resulted in an 
improvement in peptide identification. This improvement was due in large part to the fact 
that the UVnovo program exploited the individual attributes of UVPD and CID spectra in 
a way that mitigated the shortcomings of either CID or UVPD spectra alone. In addition 
to incorporation of paired spectra, the de novo program was also modified to allow the 
use of sequence tags that were matched to a known database so the program could be 
used as a hybrid de novo/database search method. 
In Chapter 6, peptide characterization of six peptides wass performed using 266 
nm UVPD. Fragmentation data collected for these peptides was compared to collision 
induced dissociation (CID) and 193 nm UVPD to better understand characteristics and 
pathways of 266 nm UVPD fragmentation based on charge state and amino acid 
composition. 
In summary, UVPD was utilized for peptide characterization or used in tandem 
with derivatization of peptides to attach UV chromophores to generate spectra ideal for 
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de novo sequencing by eliminating b-ions from MS/MS spectra. A de novo sequencing 
algorithm was used to maximize the utility of the unique fragmentation patterns produced 
by UVPD, allowing thousands of peptides to be confidently sequenced. The novel de 
novo method also allowed paired UVPD/CID spectra to be searched which allowed it to 
be used to match peptides to a known database by the implementation of sequence tags. 
Future effort could be envisioned in two areas. First, there would be huge benefits 
to using the novel 351 nm UVPD de novo method for high accuracy mass spectra. The 
use of high resolution/high accuracy spectra will afford significant improvement in the 
assignment of the precursor mass of peptides which plays a crucial role in the ability of 
the de novo program to assign the correct composition and number of amino acids in a 
peptide. Furthermore, high mass accuracy greatly reduces the possible number of 
sequence combinations feasible for a precursor mass, thus reducing the ambiguity in 
sequence assignment. The use of high resolution data will also allow differentiation of 
amino acid pairs from single amino acids which share the same nominal mass. For 
example a loss of a GV pair of amino acids from a peptide sequence has a similar 
nominal mass as a loss of R based on low resolution mass analysis, whereas high 
resolution data can easily distinguish between the two. With all of these benefits the use 
of high resolution in tandem with this 351 nm de novo program should result in a 
significant improvement in the confidence of de novo sequencing results. 
Secondly, the use of the AMCA/351 nm UVPD method being applied to data 
independent acquisition (DIA) strategies is a compelling target of opportunity. DIA is a 
method for data collection where all peptides in a defined m/z range (such as a 25 Da 
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interval) are activated and dissociated simultaneously (rather than one selected ion at a 
time), allowing several peptides to be identified at once.  Although the resulting MS/MS 
pattern is a conglomeration of all the fragment ions from all the peptide precursors in the 
25 Da window, identification of these peptides is typically performed by an extensive 
computational reconstruction of fragmentation spectra from complex data sets. The use of 
DIA has gained significant interest in recent years as it does not suffer from a bias in 
peak selection process, a common sampling problem in data dependent acquisition 
(DDA) in which individual peptide masses are isolated and activated to generate MS/MS 
spectra. For DDA methods, typically the ten most abundant ions observed in an MS1 
spectra are sequentially selected for isolation and activation.  The bias in peak selections 
results in low abundance ions often being missed as the program overlooks them in favor 
of more abundant peaks for analysis. Due to the fact that DIA simultaneously activates 
and dissociates multiple peptides within a m/z range, it currently faces the problem of 
processing extremely complex data from congested, conglomerated MS/MS spectra. I 
believe the AMCA/351 nm UVPD method could overcome some of the problems 
associated with DIA strategies. The fragmentation of peptides with the 351 nm UVPD 
method greatly reduces the complexity of MS/MS spectra being analyzed. The analysis 
of these simplified spectra with a DIA program method should streamline the spectral 
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